Annual Report • Jun 19, 2020
Annual Report
Open in ViewerOpens in native device viewer
Company Number : 01860181
| Directors | J M Downing | |||
|---|---|---|---|---|
| O R Tant | ||||
| T R W Tildesley | ||||
| M A Wall | ||||
| Company Secretary | T M Williams | |||
| Registered Number | 01860181 | |||
| Registered Office | 121 Winterstoke Road | |||
| Bristol | ||||
| BS3 2LL | ||||
| Independent Auditors | PricewaterhouseCoopers LLP | |||
| Chartered Accountants and Statutory Auditors | ||||
| 2 Glass Wharf | ||||
| Bristol | ||||
| BS2 0FR | ||||
| United Kingdom |
The Directors present their Strategic Report together with the Directors' Report and audited financial statements of Imperial Tobacco Limited (the Company) for the year ended 30 September 2019.
The principal activity of the Company is the marketing and sale of tobacco, tobacco-related and next generation products. The Company is also a holding company and intermediate parent company for the majority of the operating subsidiaries of the Imperial Brands PLC Group (the Group).
The Company is a wholly owned indirect subsidiary of Imperial Brands PLC, which is the ultimate parent company within the Group. The Company results incorporate both the UK trading of the Group and the head office functions, with key performance indicators being focussed on the UK market trading. Key performance indicators used by management to monitor the UK trading element only are detailed below.
| 2019 | 2018 | Movement | |
|---|---|---|---|
| Market share (%) | 40.2% | 42.1% | -189bps |
| Net revenue (£m) | 570 | 593 | -4% |
| Operating profit (£m) | 405 | 372 | 9% |
Year on year volumes have declined 1.7 billion stick equivalents. This is mainly due to a reduction in market size of 6.7 percent driven largely by factory manufactured cigarettes, partially offset by size growth within fine cut tobacco. Share has also declined over the same period resulting in volume reduction of 500 million stick equivalents coming from sub-economy and mid-priced brands.
Net revenue comprises tobacco revenue less duty and similar items, excluding peripheral products. In addition to the UK trading revenue of £3,933 million (2018: £4,144 million), the Company recognised £277m (2018: £288 million) licence fee income and £18 million (2018: £13 million) revenue from NGP products.
In addition to tobacco operating profit of £405 million (2018: £372 million) for the UK trading business, the Company recognised operating income in respect of licence fees and head office royalties. These are offset by an operating loss in the NGP business of £23 million (2018: £11 million) and impairment of investments of £2,630 million (2018: £13,321 million).
The principal risks and uncertainties of the Company, are considered to be the following:-
These risks, and mitigating actions taken by the Company, are detailed on pages 33-39 of the Group's Annual Report which does not form part of this report, but is available at www.imperialbrandsplc.com
In the normal course of business, the Group is exposed to market, liquidity and credit risk. The Group's financial risk management policy is discussed in the Financial Risk Factors section of the Group's Annual Report, which does not form part of this report.
The operating subsidiaries of the Company are shown at the end of this report. The Company operates an overseas branch in France.
The results for the Company show profit for the financial year of £643 million (2018: loss of £63 million), operating loss of £1,936 million (2018: £12,784 million) and revenue of £4,228 million (2018 restated: £4,445 million). Total equity at 30 September 2019 is £14,510 million (2018: £13,902 million).
The Directors do not propose a final dividend (2018: £nil). The aggregate dividends on the ordinary shares recognised as a charge to the Statement of Changes in Equity during the year amounts to £nil (2018: £6,000 million).
The Company believes it is well placed to continue in its market leading position in the UK due to its broad product and brand portfolio and the initiatives in the value and economy cigarette, fine cut tobacco and next generation product (NGP) sectors. This, along with the Company's continued commitment to drive sales growth by ensuring that the Company's brand and products evolve in line with changing consumer dynamics, should provide further opportunities to grow operating profits. The Company holds investments in the Group's trading entities, providing substantial dividend income annually.
The UK formally exited from the European Union on 31 January 2020, and entered into a transition trading arrangement until 31 December 2020. The Company has looked into the potential impacts of different trading arrangements that may exist after the transition arrangements expire. The key risks that have been identified include potential increase in import duties and impact on UK customers; additional risk of tobacco smuggling, inventory requirements to ensure supply and impact on consumer confidence. In the event of no trade deal being in place by 31 December, we estimate there could be potential additional costs of around £50 million relating to possible import duties and additional stock holding.
The Company's employment policies aim to attract, retain, train and motivate the very best people, recognising that this can be achieved only through offering equal opportunities and giving fair consideration to applications for employment, career development and promotion without having regard to an employee's gender, race, religion, age or disability. These policies also cover the continuation of employment and appropriate training for employees who become disabled during their employment.
To ensure employees can share in our success, the Company offers competitive pay and benefit packages linked, wherever possible, to performance. Employees are encouraged to build an ownership stake in Imperial Brands PLC shares, with a number of employee share plans offered during the year.
The Company is committed to providing an environment that encourages the continuous development of all its employees through skills enhancement and training programmes.
Employees are kept aware of the financial and economic factors affecting the performance of the Company. The Company provides employees systematically with information on matters of concern to them, and consults employees or representatives on a regular basis so views of employees are taken into account when making decisions. To progress this aim further employee representatives are briefed on pan-European issues through the Imperial Tobacco European Employee Works Council.
Information concerning employees and their remuneration is given in note 6 to the financial statements.
In March 2020 the Imperial Brands Group was impacted by the global Coronavirus (Covid-19) pandemic, which resulted in unprecedented government restrictions on the normal operations of the Group across many countries. The restrictions put in place initially resulted in a number of office and factory closures. The Group has responded by adapting working practices through activities such as strengthening our IT infrastructure and accelerating the roll-out of software to facilitate remote team-working, as well as encouraging a more flexible approach. There have been modifications to working practices including changing shift patterns to ensure appropriate infection controls and social distancing for employees in manufacturing facilities. As a result of this, manufacturing plants have continued to operate and the Group is able to both produce and distribute product to customers to meet demand, while complying with all necessary safety precautions to protect staff and business partners from the risks arising from the pandemic.
As the pandemic commenced in 2020 this represents a non adjusting post balance sheet event with regards to the financial statements of the Company for the year ending 30 September 2019.
To date, the observable impacts on the Company's activities have been limited to low level changes in credit risk in the duty free and travel retail operations area. The Company is not aware of any post year end impairments to its investments specifically associated with the impact of the pandemic.
A review of the key financial assumptions relating to the Company's defined benefit pension scheme subsequent to the balance sheet date indicates that the fair value of plan assets is expected to be volatile in the short term due to uncertain market conditions.
On behalf of the Board
T R W Tildesley Director 15 June 2020
The Directors submit their report together with the Strategic Report and audited financial statements of the Company for the year to 30 September 2019.
Future developments are set out in the Strategic Report.
The Directors are satisfied that the Company has adequate resources to meet its operational needs for the foreseeable future. The Company has net current liabilities of £9,002 million as at 30 September 2019, including £8,917 million relating to intra-group payables and receivables. The Directors of the Company have assurances of unconditional committed financial support from Imperial Brands PLC, the ultimate parent company, and that this will continue for at least 12 months from the date of signing of the financial statements. Therefore the Directors continue to adopt the going concern basis in preparing the financial statements.
Financial risk management policies are detailed in the Strategic Report.
Details of the Company's share capital are shown in note 20 to the financial statements.
As set out in the Strategic Report, the Directors do not propose a final dividend (2018: £nil). No interim dividends have been paid (2018: £318.62 per ordinary share amounting to £6,000 million).
Imperial Brands PLC has purchased Directors' and Officers' liability insurance that has been in force during the financial year and is currently in force at the date of approval of these financial statements. The Directors of the Company have the benefit of this insurance, which is a qualifying third party indemnity provision as defined by the Companies Act 2006.
The Directors of the Company who were in office during the year and up to the date of signing the financial statements were:
The Company's policy on involving UK employees in its affairs is set out in the Strategic Report.
The Company operates an overseas branch in France.
The Directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulation.
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have prepared the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising FRS 101 'Reduced Disclosure Framework', and applicable law).
Under Company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing the financial statements, the Directors are required to:
The Directors are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006.
In the case of each Director in office at the date the Directors' Report is approved:
A decision to tender the audit was made by the Board of Imperial Brands PLC and due to the length of its tenure our auditor PricewaterhouseCoopers LLP was not invited to participate. In February 2019 the Board of Imperial Brands PLC made a decision to appoint Ernst & Young as auditor. PricewaterhouseCoopers LLP will resign following the completion of the audit of these financial statements allowing the new auditors to be appointed.
On behalf of the Board
T R W Tildesley Director 15 June 2020
In our opinion, Imperial Tobacco Limited's financial statements:
We have audited the financial statements, included within the Financial Statements (the "Annual Report"), which comprise: the Balance Sheet as at 30 September 2019; the Income Statement, the Statement of Comprehensive Income and the Statement of Changes in Equity for the year then ended; and the notes to the financial statements, which include a description of the significant accounting policies.
We conducted our audit in accordance with International Standards on Auditing (UK) ("ISAs (UK)") and applicable law. Our responsibilities under ISAs (UK) are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
We remained independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, which includes the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.
We have nothing to report in respect of the following matters in relation to which ISAs (UK) require us to report to you where:
However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the Company's ability to continue as a going concern.
The other information comprises all of the information in the Annual Report other than the financial statements and our auditors' report thereon. The Directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, accordingly, we do not express an audit opinion or, except to the extent otherwise explicitly stated in this report, any form of assurance thereon.
Reporting on other information (continued)
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If we identify an apparent material inconsistency or material misstatement, we are required to perform procedures to conclude whether there is a material misstatement of the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report based on these responsibilities.
With respect to the Strategic Report and Directors' Report, we also considered whether the disclosures required by the UK Companies Act 2006 have been included.
Based on the responsibilities described above and our work undertaken in the course of the audit, ISAs (UK) require us also to report certain opinions and matters as described below.
In our opinion, based on the work undertaken in the course of the audit, the information given in the Strategic Report and Directors' Report for the year ended 30 September 2019 is consistent with the financial statements and has been prepared in accordance with applicable legal requirements.
In light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we did not identify any material misstatements in the Strategic Report and Directors' Report.
As explained more fully in the Statement of Directors' responsibilities in respect of the financial statements, the Directors are responsible for the preparation of the financial statements in accordance with the applicable framework and for being satisfied that they give a true and fair view. The Directors are also responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
A further description of our responsibilities for the audit of the financial statements is located on the FRC's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditors' report.
This report, including the opinions, has been prepared for and only for the Company's members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.
Companies Act 2006 exception reporting Under the Companies Act 2006 we are required to report to you if, in our opinion:
We have no exceptions to report arising from this responsibility.
Richard French (Senior Statutory Auditor) for and on behalf of PricewaterhouseCoopers LLP Chartered Accountants and Statutory Auditors Bristol 15 June 2020
For the year ended 30 September
| 2018 | |||
|---|---|---|---|
| (In £ million) | Note | 2019 | Restated (1) |
| Revenue | 4 | 4,228 | 4,445 |
| Duty and similar items | (3,363) | (3,590) | |
| Other cost of sales | (125) | (133) | |
| Cost of sales | (3,488) | (3,723) | |
| Gross profit | 740 | 722 | |
| Distribution, advertising and selling costs | (139) | (114) | |
| Impairment of investments | 5 | (2,630) | (13,321) |
| Restructuring costs | 5 | (22) | (36) |
| UK distributor exceptional | 5 | - | (110) |
| Profit on disposal of buildings | - | 40 | |
| Other administrative income | 115 | 35 | |
| Administrative and other expenses | 93 | (71) | |
| Operating loss | 5 | (1,936) | (12,784) |
| Income from shares in group undertakings | 2,931 | 13,111 | |
| Finance income | 7 | 23 | 43 |
| Finance costs | 8 | (305) | (367) |
| Other finance income - pensions | 17 | 10 | |
| Net finance costs | (265) | (314) | |
| Profit before taxation | 730 | 13 | |
| Tax on profit | 9 | (87) | (76) |
| Profit/(loss) for the financial year | 643 | (63) |
(1) See note 2 Accounting Policies for details of the restatement in respect of the year ending 30 September 2018.
For the year ended 30 September
| (In £ million) | Note | 2019 | 2018 |
|---|---|---|---|
| Profit/(loss) for the financial year | 643 | (63) | |
| Other comprehensive (expense)/income | |||
| Exchange movements | (3) | 18 | |
| Items that may be reclassified to profit and loss | (3) | 18 | |
| Actuarial (loss)/gain on pension scheme | 19 | (65) | 155 |
| Deferred tax relating to actuarial movement on pension scheme | 11 | (26) | |
| Items that will not be reclassified to profit and loss | (54) | 129 | |
| Other comprehensive (expense)/income for the year, net of tax | (57) | 147 | |
| Total comprehensive income for the year | 586 | 84 |
At 30 September
| (In £ million) | Note | 2019 | 2018 |
|---|---|---|---|
| Fixed assets | |||
| Intangible assets | 11 | 61 | 55 |
| Investments | 12 | 23,523 | 23,746 |
| Property, plant and equipment | 13 | 17 | 16 |
| 23,601 | 23,817 | ||
| Current assets | |||
| Retirement benefit assets - amounts falling due after more than one year | 19 | 536 | 522 |
| Inventories | 14 | 34 | 60 |
| Debtors: amounts falling due within one year | 15 | 435 | 342 |
| Cash at bank and in hand | 11 | 12 | |
| 1,016 | 936 | ||
| Creditors: amounts falling due within one year | 16 | (10,018) | (10,765) |
| Net current liabilities | (9,002) | (9,829) | |
| Total assets less current liabilities | 14,599 | 13,988 | |
| Provisions for liabilities | 17 | (6) | (10) |
| Deferred tax liabilities | 18 | (83) | (76) |
| Net assets | 14,510 | 13,902 | |
| Equity | |||
| Called up share capital | 20 | 19 | 19 |
| Share premium account | 11,620 | 11,620 | |
| Retained earnings | 2,871 | 2,263 | |
| Total equity | 14,510 | 13,902 |
The notes on pages 14 to 64 are an integral part of these financial statements.
The financial statements on pages 10 to 64 were approved by the Board of Directors on 15 June 2020 and signed on its behalf by:
Director Director
Company Number : 01860181
O R Tant T R W Tildesley
| Called up | Share premium | Capital | Retained | ||
|---|---|---|---|---|---|
| (In £ million) | share capital | account | reserves | earnings | Total equity |
| At 30 September 2018 | 19 | 11,620 | - | 2,263 | 13,902 |
| IFRS 9 Transition | - | - | - | (1) | (1) |
| At 1 October 2018 | 19 | 11,620 | - | 2,262 | 13,901 |
| Profit for the financial year | - | - | - | 643 | 643 |
| Exchange movements | - | - | - | (3) | (3) |
| Actuarial expense on pension scheme | - | - | - | (65) | (65) |
| Deferred tax relating to actuarial | |||||
| movement on pension scheme | - | - | - | 11 | 11 |
| Other comprehensive expense | - | - | - | (57) | (57) |
| Total comprehensive income | - | - | - | 586 | 586 |
| Transactions with owners | |||||
| Costs of employees' services | |||||
| compensated by share schemes | - | - | - | 23 | 23 |
| At 30 September 2019 | 19 | 11,620 | - | 2,871 | 14,510 |
| At 1 October 2017 | 19 | 15,620 | - | 4,154 | 19,793 |
| Loss for the financial year | - | - | - | (63) | (63) |
| Exchange movements | - | - | - | 18 | 18 |
| Actuarial gain on pension scheme | - | - | - | 155 | 155 |
| Deferred tax relating to actuarial | |||||
| movement | - | - | - | (26) | (26) |
| Other comprehensive income | - | - | - | 147 | 147 |
| Total comprehensive income | - | - | - | 84 | 84 |
| Transactions with owners | |||||
| Costs of employees' services | |||||
| compensated by share schemes | - | - | - | 25 | 25 |
| Share premium reduction | - | (4,000) | 4000 | - | - |
| Dividends paid | - | - | (4,000) | (2,000) | (6,000) |
| At 30 September 2018 | 19 | 11,620 | - | 2,263 | 13,902 |
The financial statements of the Company for the year ended 30 September 2019 were authorised for issue by the board of directors on 15 June 2020, and the balance sheet was signed on the board's behalf by O R Tant and T R W Tildesley. Imperial Tobacco Limited is a private company limited by shares incorporated and domiciled in the United Kingdom and registered in England and Wales.
These financial statements were prepared in accordance with the Companies Act 2006, Financial Reporting Standard 101 Reduced Disclosure Framework (FRS 101) and applicable accounting standards.
The Company's financial statements are presented in Sterling and all values are rounded to the nearest million pounds (£m) except when otherwise indicated.
The Company has taken advantage of the exemption under s400 of the Companies Act 2006 not to prepare group financial statements as it is a wholly owned subsidiary of Imperial Brands PLC, registered in the United Kingdom. The results of the Company are included in the consolidated financial statements of Imperial Brands PLC which are available from 121 Winterstoke Road, Bristol, BS3 2LL or on its website www.imperialbrandsplc.com.
The financial statements have been prepared in accordance with the Companies Act 2006 as applicable to Companies using Financial Reporting Standard 101 'Reduced Disclosure Framework' (FRS 101), and FRS 101 as issued by the Financial Reporting Council, on a going concern basis. The financial statements have been prepared consistently during the current and preceding year, except for newly applicable standards.
The financial statements have been prepared on the historical cost basis, except as described in the accounting policies on foreign currency and investments below. Historical cost is generally based on the fair value of the consideration given in exchange for the assets.
The preparation of the financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues and expenses during the period and of assets and liabilities at the balance sheet date. The key estimates and assumptions are set out in note 3 Critical Accounting Estimates and Judgements. Such estimates and assumptions are based on historical experience and various other factors that are believed to be reasonable in the circumstances and constitute management's best judgement at the date of the financial statements. In the future, actual experience may deviate from these estimates and assumptions. This could affect future financial statements as the original estimates and assumptions are modified, as appropriate, in the year in which the circumstances change.
The Directors are satisfied that the Company has adequate resources to meet its operational needs for the foreseeable future. The Company has net current liabilities of £9,002 million as at 30 September 2019, including £8,917 million relating to intra-group payables and receivables. The Directors of the Company have assurances of unconditional committed financial support from Imperial Brands PLC, the ultimate parent company, and that this will continue for at least 12 months from the date of signing of the financial statements. Therefore the Directors continue to adopt the going concern basis in preparing the financial statements.
As permitted by FRS 101, the Company has taken advantage of the disclosure exemptions available in the preparation of the financial statements, as detailed below:
The Company has adopted IFRS 9 'Financial Instruments' and IFRS 15 'Revenue from Contracts with Customers' with effect from 1 October 2018. The detail of adoption is provided below. There have been no other new standards or amendments which became effective for the current reporting period that have had a material effect on the Company.
On 1 October 2018 the Company adopted IFRS 9 'Financial Instruments', with no revision of prior periods as permitted by the standard. IFRS 9 has replaced IAS 39 'Financial Instruments: Recognition and Measurement' and includes revised guidance on:
Classification and measurement: Financial assets are now classified as either being accounted for as amortised cost, fair value through other comprehensive income, or fair value through profit or loss. There are no changes to the classification or accounting for financial liabilities. Other than trade receivables, the Company does not currently hold any significant financial assets.
The Company has revised the classification of certain trade receivables which are subject to a non-recourse factoring arrangement. This arrangement covers various customer accounts. Prior to the adoption of IFRS 9 all trade receivables were recognised at amortised cost. Where trade receivables may be sold in the future under a factoring arrangement that involves realising cash flows through the sale of assets in order to manage customer credit risk, they are now classified as fair value through other comprehensive income (OCI). Under this classification, valuation changes are recognised in the OCI. The level of trade receivables that were sold to a financial institution under a nonrecourse factoring arrangement totalled £325 million at 1 October 2018 and £345 million at 30 September 2019. The total value of trade receivables reclassified as fair value through OCI was £10 million at 1 October 2018 and £19 million at 30 September 2019. On adoption of the standard there was no valuation difference and therefore the OCI has not been impacted. Trade receivables managed under a "hold to collect" business model continue to be measured at amortised cost.
The Company does not undertake any supply chain financing activity.
Impairment of financial assets: Impairment provisions are calculated using a forward looking expected credit loss approach for financial assets, rather than the incurred loss approach applicable under IAS 39. The expected credit loss model requires the recognition of a provision which reflects future impairment risk. Provision levels are calculated on the residual credit risk after consideration of any credit protection which is used by the Company.
Under the revised Trade Receivables provisioning policy, expected future credit loss provisions are now recognised in addition to doubtful debt provisions on receivables which have already become overdue. With the exception of the Palmer and Harvey debt write-off in 2018, the Company has historically experienced low levels of credit default. On adoption of the standard the Company has recognised an additional expected credit loss provision of £1 million, with the costs being recognised directly in equity within the retained earnings reserve at 1 October 2018.
Hedge Accounting: IFRS 9 aligns the accounting approach with an entity's risk management strategies and risk management objectives. The Company has adopted the hedge accounting aspects of IFRS 9 prospectively from 1 October 2018. The Company continues to apply net investment hedging as part of its risk management approach. All hedging relationships that existed at 30 September 2018 continue to apply under IFRS 9. The adoption of this area of IFRS 9 has not had any significant impact on the financial statements.
On 1 October 2018 the Company adopted IFRS 15 'Revenue from Contracts with Customers', the Company has restated prior periods as permitted by the standard. IFRS 15 has introduced an amended framework for revenue recognition and has replaced the prior guidance in IAS 18 'Revenue'. The accounting policies have been revised and applied to both the current and prior period. The standard provides revised guidance on revenue accounting, matching income recognition to the delivery of performance obligations in contractual arrangements for the provision of goods or services. It also provides different guidance on the measurement of revenue contracts involving discounts, rebates and payments to customers.
IFRS 16 'Leases' will be effective for the period beginning 1 October 2019. The new standard requires operating leases to be accounted for through the recognition of a 'right of use asset' and a corresponding lease liability. Interestbearing borrowings and non-current assets will increase on implementation of this standard. Operating lease costs will no longer be classified within the income statement based on amounts paid, but via a 'right of use asset' depreciation charge recognised within operating profit and a lease interest expense within finance costs. The Company will take advantage of the practical expedients under the standard by not applying IFRS16 to short terms leases (Leases of less than 12 months maximum term) and to leases of low-value assets.
As permitted by the standard, the Company will apply the modified retrospective approach with no restatement of prior year. On adoption of IFRS 16 the expected impact is approximately £42 million increase in non-current assets and £42 million increase in liabilities.
IFRIC 23 'Uncertainty over income tax treatments' will be effective, subject to EU endorsement, for the period beginning 1 October 2019. The Interpretation clarifies how to apply the recognition and measurement requirements in IAS 12 when there is uncertainty over income tax treatments. The adoption of this interpretation is not expected to have a material effect on the Company's net assets or results.
| Year ended 30 September 2018 | ||||
|---|---|---|---|---|
| Previously | IFRS 15 | |||
| (In £ million) | reported | adjustment | Restated | |
| Revenue | 4,485 | (40) | 4,445 | |
| Duty and similar items | (3,590) | - | (3,590) | |
| Net revenue | 895 | (40) | 855 | |
| Other cost of sales | (133) | - | (133) | |
| Gross profit | 762 | (40) | 722 | |
| Distribution, advertising and selling costs | (154) | 40 | (114) | |
| Impairment of investments | (13,321) | - | (13,321) | |
| Administrative and other expenses | (71) | - | (71) | |
| Operating loss | (12,784) | - | (12,784) |
Monetary assets and liabilities denominated in foreign currencies are translated into pound sterling at the rates of exchange ruling at the balance sheet date.
Transactions in currencies other than pound sterling are initially recorded at the exchange rate ruling at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at exchange rates ruling at the balance sheet date of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement with exchange differences arising on trading transactions being reported in operating profit, and those arising on financing transactions being reported in net finance costs.
The carrying amounts of foreign currency investments are translated at the rates of exchange ruling at the balance sheet date and resulting exchange differences are offset against exchange gains or losses on the translation of intragroup borrowings in reserves, through the Statement of Comprehensive Income.
The Company holds fair value hedges against certain investments. Gains or losses on these hedges, that are regarded as highly effective, are taken to the income statement, where they offset gains or losses on translation of the investments within net finance income / costs.
Revenue comprises the invoiced value for the sale of goods and services net of sales taxes, rebates and discounts. Revenue is based on the completion of performance obligations that constitute the delivery of goods and completion of services. The performance obligation is recognised as complete at the point in time when a Group company has delivered products to the customer, the customer has accepted the products and collectability of the related receivables is reasonably assured. Performance obligations associated with services, which include fees for distributing certain third party products, are linked to the delivery of those services. Income arising from the licencing or sale of intellectual property, occurring in the ordinary course of business, is treated as revenue. Licencing revenue will be recognised over the period of the licence while revenue is recognised immediately on the sale of intellectual property where that represents a long-term right to use the asset.
Payments are made to both direct and indirect customers for rebates, discounts and other promotional activities. Direct customers are those to which the Group supplies goods or services. Indirect customers are other entities within the supply chain to the end consumer. Rebates and discounts are deducted from Revenue. Payments for promotional activities will also be deducted from Revenue where the payments relate to goods or service that are closely related to or indistinct from associated sales of goods or services to that customer. The calculated costs are accrued and accounted for as incurred and matched as a deduction from the associated revenues (i.e. excluded from revenues reported in the Group's consolidated income statement).
Duty and similar items includes duty and levies having the characteristics of duty. As the duty is a production tax, duty is included in revenue and in cost of sales in the income statement.
Dividend income from subsidiary entities is recognised in the period in which the right to receive payment is established.
Interest payable and receivable is recognised in the income statement on an accrual basis.
The tax expense for the year comprises current and deferred tax. Tax is recognised in the income statement, except to the extent that it relates to items recognised in other comprehensive income or directly in shareholders' funds. In this case, the tax is also recognised in other comprehensive income or directly in the shareholders' funds, respectively.
Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the balance sheet date, and any adjustments to tax payable in respect of previous periods.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date.
A net deferred tax asset is recognised only to the extent that it is probable that future taxable profit will be available against which the asset can be utilised.
Deferred tax is determined using tax rates that have been enacted or substantively enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised or the deferred tax liability is settled. Deferred tax is measured on a non-discounted basis.
Final dividends are recognised as a liability in the period in which the dividends are approved by shareholders, whereas interim dividends are recognised in the period in which the dividends are paid.
Intangible assets are shown in the balance sheet at historical cost less accumulated amortisation and impairment. Costs incurred after initial recognition are included in the assets' carrying amounts or recognised as a separate asset as appropriate only when it is probable that future economic benefits associated with them will flow to the Company and the cost of the item can be measured reliably.
Intangible assets comprise software and intellectual property. Intangible assets are amortised so as to write down the initial costs of each asset to its residual value on a straight line basis over its estimated useful life of between 3 and 10 years.
Investments held as fixed assets comprise the Company's investment in subsidiaries and are predominantly shown at historic purchase cost less any provision for impairment. The exception is when a fair value hedge is in place whereby the investment is revalued at the rate prevailing at the period end, with any foreign exchange movement taken to the net finance income / costs.
Investments are tested for impairment annually to ensure that the carrying value of the investment is supported by their underlying net assets.
Property, plant and equipment are shown in the balance sheet at historical cost less accumulated depreciation and impairment. Costs incurred after initial recognition are included in the assets' carrying amounts or recognised as a separate asset as appropriate only when it is probable that future economic benefits associated with them will flow to the Company and the cost of the item can be measured reliably.
Land is not depreciated. Depreciation is provided on other property, plant and equipment so as to write down the initial cost of each asset to its residual value over its estimated useful life as follows:
| Land and buildings | up to 50 years | straight line |
|---|---|---|
| Plant and machinery | 5 - 17 years | straight line / reducing balance |
| Fixtures and motor vehicles | 3 - 4 years | straight line |
Inventories are stated at the lower of cost and net realisable value. Cost is determined using the first in first out (FIFO) method. The cost of finished goods comprises raw materials, direct labour, other direct costs and related production overheads (based on normal operating capacity). Net realisable value is the estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses.
A provision is recognised in the balance sheet when the Company has a legal or constructive obligation as a result of a past event, it is more likely than not that an outflow of resources will be required to settle that obligation, and a reliable estimate of the amount can be made.
A provision for restructuring is recognised when the Company has approved a detailed formal restructuring plan, and the restructuring has either commenced or has been publicly announced, and it is more likely than not that the plan will be implemented, and the amount required to settle any obligations arising can be reliably estimated. Future operating losses are not provided for.
Following the adoption of IFRS 9, the Group's accounting policies for financial instruments and hedging remain the same as disclosed in the 30 September 2018 annual report and accounts, except for changes to the classification and measurement of certain non-derivative financial assets and the calculation of expected credit losses, as detailed below.
At 30 September 2018 all non-derivative financial assets were classified as loans and receivables. Receivables were all initially recognised at fair value and subsequently stated at amortised cost using the effective interest method. From 1 October 2018, receivables held under a "hold to collect" business model continue to be stated at amortised cost. Receivables held under a "hold to sell" business model, which are expected to be sold via a non-recourse factoring arrangement are now separately classified at fair value through profit or loss, within trade and other receivables.
At 30 September 2018, provisions for the impairment of receivables were established when there was objective evidence that the Group would not be able to collect all amounts due according to the original terms of those receivables. Provisions were only recognised when an impairment had crystallised. From 1 October 2018 the calculation of impairment provisions is subject to an expected credit loss model, involving a prediction of future credit losses based on past loss patterns. The revised approach involves the recognition of provisions relating to potential future impairments, in addition to impairments that have already occurred. The expected credit loss approach involves the modelling of historic loss rates, and the consideration of the level of future credit risk. Expected loss rates are then applied to the gross receivables balance to calculate the impairment provision.
Cash and cash equivalents include cash in hand and deposits held on call, together with other short-term highly liquid investments.
The Company participates, together with other group companies, in a pension scheme for its employees, the Imperial Tobacco Pension Fund (the Scheme), which is of a defined benefit type. As it has not been possible to identify the underlying assets and liabilities attributable to each participating company on a consistent and reasonable basis the Company recognises the entire Scheme in these financial statements as the "sponsoring company" in the Scheme.
The amount recognised in the balance sheet is the difference between the present value of the defined benefit obligation at the balance sheet date and the fair value of the scheme assets to the extent that they are demonstrably recoverable either by refund or a reduction in future contributions. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash flows using interest rates of high quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension obligation.
The service cost of providing retirement benefits to employees during the year is charged to operating profit. Past service costs are recognised immediately in operating profit, unless the changes to the pension plan are conditional on the employees remaining in service for a specified period of time.
All actuarial gains and losses, including differences between actual and expected returns on assets and differences that arise as a result of changes in actuarial assumptions, are recognised immediately in full in the statement of comprehensive income for the period in which they arise. An interest charge is made in the income statement by applying the rate used to discount the defined benefit obligations to the net defined benefit liability of the schemes.
For defined contribution schemes, contributions are recognised as an employee benefit expense when they are due.
Equity-settled share-based payments are measured at fair value at the date of grant and are expensed over the vesting period, based on the number of instruments that are expected to vest. For plans where vesting conditions are based on total shareholder returns, the fair value at the date of grant reflects these conditions. Earnings per share and net revenue vesting conditions are reflected in the estimate of awards that will eventually vest. Where applicable the Company recognises the impact of revisions to original estimates in the income statement, with a corresponding adjustment to equity. Fair values are measured using appropriate valuation models, taking into account the terms and conditions of the awards.
The Company makes estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience, and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
In the future, actual experience may deviate from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the current financial year are discussed below.
The Company holds provisions where appropriate in respect of estimated future economic outflows, principally for restructuring activity, which arise due to past events. Estimates are based on management's judgement and information available at the balance sheet date. Actual outflows may not occur as anticipated, and estimates may prove to be incorrect, leading to further charges or releases of provisions as circumstances dictate.
The Company holds investments in subsidiary undertakings, the value of which is assessed on an annual basis. Estimates of future cashflows are used to provide valuations of the subsidiary entities, and where there are indications that the current carrying value of the investment is greater than the valuation of the business, impairment of the investment may be required.
The complexity of the estimation process and issues related to the assumptions, risks and uncertainties inherent in the application of the accounting estimates affect the carrying values reported in the financial statements. If business conditions were different, or if different assumptions were used in the calculation of accounting estimates, it is possible that different amounts could be reported.
Accounting for retirement benefits uses a number of accounting estimates. The valuation of the scheme requires estimates of various market, demographic and mortality assumptions, which are fully reviewed by external actuaries. Full disclosure of the estimates used in retirement benefit accounting is included within note 19.
The Company is engaged in only one class of business; the marketing and sale of tobacco and tobacco-related products, and the marketing and sales of next generation products (NGP).
Revenue is attributed solely to UK activities and accordingly no geographical analysis of revenue, operating profit or capital employed is shown.
Operating loss is stated after (crediting)/charging:
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Changes in inventories of finished goods and work in progress (pre-duty) | (1) | 22 |
| Amortisation | 7 | 7 |
| Profit on disposal of non-current assets | - | (38) |
| Depreciation | 5 | 6 |
| Impairment of investments | 2,630 | 13,321 |
| UK distributor exceptional | - | 110 |
| Restructuring costs | 22 | 36 |
Restructuring charges above of £22 million (2018: £36 million) relate mainly to the Group's cost optimisation programme. These charges cover employee costs, fixed asset and stock impairment, and other costs such as those for decommissioning.
During the year, following receipt of a dividend of £2,335m the Company impaired its investment in Imperial Tobacco Management Luxemburg sarl by £2,335 million. The Company has assessed the carrying value of its investments at 30 September 2019, and recorded a further impairment in Imperial Tobacco Management Luxembourg sarl of £57 million, and an impairment of £238 million in its investment in Altadis Middle East FZCO.
During the prior year the Company undertook a group simplification and re-organisation, receiving dividends of £12,100 million from Imperial Tobacco Holdings (1) Limited and subsequently made a provision against the carrying value of this investment in subsidiary by £11,127 million. An impairment in the investment in SEITA of £2,194 million was also recorded.
On 28 November 2017 Palmer & Harvey (P&H) announced that it had entered administration. P&H had been a longstanding trading partner in the UK, however no significant disruption to UK operations occurred. As a result the Company incurred a one-off impact to operating profit of £110 million in the prior year, the majority of which relates to excise duty which is non-recoverable.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Audit of the Company financial statements | 0.1 | 0.1 |
No non-audit services were provided by the Auditors.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Wages and salaries | 121 | 105 |
| Social security costs | 10 | 14 |
| Other pension costs (note 19) | 27 | 32 |
| Share-based payments (note 23) | 16 | 13 |
| 174 | 164 |
Pensions cost comprise £23 million cost (2018: £28 million) in respect of the defined benefit scheme, and £4 million costs (2018: £4 million cost) in respect of the defined contribution scheme.
| Number of employees by activity | 2019 | 2018 |
|---|---|---|
| Production | 88 | 141 |
| Selling and distribution | 641 | 630 |
| Administration | 248 | 289 |
| 977 | 1,060 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Emoluments | 2,753 | 4,294 |
| LTIP annual vesting 1 | - | 319 |
| SMS annual vesting 1 | 124 | 137 |
| Total aggregate emoluments | 2,877 | 4,750 |
1 During the year, one Director (2018: two) exercised share options, and received shares under the Long Term Incentive Plan (LTIP) and Share Matching Scheme (SMS). No former Directors (2018: nil) additionally exercised share options under the LTIP scheme during the year. A total of 4,693 shares with a market value of £124,234 were exercised, moreover, none of the 4,693 shares relate to the highest paid director.
The total aggregate emoluments of the highest paid Director were £1,399,901 (2018: £2,467,327), including LTIP payments of £nil (2018: £297,197) and pension benefits of £191,360 (2018: £186,680).
The Company did not pay any emoluments to past Directors (2018: three past Directors totalling £5,195,534, including LTIP payments of £691,068). No pension payments were made to former Directors.
Retirement benefits are accruing under a defined benefit scheme, in respect of qualifying services of all of the Company's Directors, with the exception of any Director whose services to the Company commenced after 30 September 2010 in which case retirement benefits are accruing on a defined contribution basis.
The Company contributions paid to the UK defined contribution scheme in respect of three Directors (2018: three) were £20,000 (2018: £26,661).
The highest paid Director in continuing service is a member of the UK defined contribution scheme and the value of their accrued Retirement Account if they had left service at the year end was £266,133 (2018: £244,358).
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Interest receivable from Group undertakings | 1 | 1 |
| Interest receivable on bank deposits | - | 1 |
| Fair value gains associated with re-translation of investments | - | 41 |
| Fair value gains associated with hedges on foreign currency movements on | ||
| investments | 22 | - |
| 23 | 43 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Interest payable to Group undertakings | 279 | 325 |
| Interest payable on bank deposits | 4 | 1 |
| Fair value losses associated with re-translation of investments | 22 | - |
| Fair value losses associated with hedges on foreign currency movements on | ||
| investments | - | 41 |
| 305 | 367 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Current tax | ||
| UK corporation tax on profits for the year | 82 | 45 |
| Controlled foreign company charge | 6 | 7 |
| Adjustments in respect of prior years | (19) | 11 |
| Total current tax | 69 | 63 |
| Deferred tax | ||
| Origination and reversal of timing differences | 2 | 2 |
| Adjustments in respect of prior years | 2 | - |
| Movement in respect of pension scheme | 14 | 11 |
| Total deferred tax | 18 | 13 |
| Total tax | 87 | 76 |
The tax assessed for the year is lower (2018: higher) than the standard rate of corporation tax in the UK of 19.0 per cent (2018: 19.0 per cent). The differences are explained as follows:
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Profit before taxation | 730 | 13 |
| Profit before taxation multiplied by standard rate of corporation tax in the UK of 19.0 | ||
| per cent (2018: 19.0 per cent). | 139 | 2 |
| Tax effects of: | ||
| Group relief claimed | (53) | (25) |
| Movement in respect of pension scheme | 14 | 10 |
| UK-UK transfer pricing adjustment | - | (1) |
| Income not subject to tax | (557) | (2,491) |
| Adjustments in respect of prior years | (17) | 11 |
| Controlled foreign company charge | 6 | 7 |
| Adjustments in respect of current year | 556 | 2,563 |
| Remeasurement of deferred tax - change in UK tax rate | (1) | - |
| Total tax charged to the income statement | 87 | 76 |
The corporation tax for the year has been adjusted by £53 million (2018: £25 million) due to the claim of group relief for nil consideration from (2018: from) other Imperial Brands PLC subsidiaries. Further adjustments to the tax charge include £500 million (2018: £2,531 million) as a permanent difference arising from investment impairments booked in the year.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| As at 1 October | 162 | 139 |
| Charged to the income statement | 69 | 63 |
| Cash paid and balance sheet movements | (78) | (40) |
| As at 30 September | 153 | 162 |
The current year tax rate of 19.0 per cent arises from profits being taxed at 19.0 per cent until 30 September 2019.
The prior period tax rate of 19.0 per cent arises from profits being taxed at 19.0 per cent until 30 September 2018. A further reduction to 17.0 per cent on 1 April 2020 was enacted at the balance sheet date.
It was announced in the March 2020 budget that the corporation tax rate of 19.0 per cent was to be maintained, this was substantively enacted on 17 March 2020. The tax impact of this on the closing deferred tax liability would be an increase of £9.7 million.
The Company continues to monitor developments in relation to EU State Aid investigations. On 25 April 2019, the EU Commission's final decision regarding its investigation into the UK's Controlled Foreign Company regime was published. It concludes that the legislation up until December 2018 does partially represent State Aid. The UK Government has appealed to the European Court seeking annulment of the EU Commission's decision. The Company, in line with a number of UK corporates, is making a similar application to the European Court. The UK Government is obliged to collect any State Aid granted pending the outcome of the European Court process. The Company has not received any indication from the UK Government as to the quantum of State Aid that it believes the Company has received, if any. The Company considers that the potential amount of additional tax payable remains between nil and £300 million depending on the basis of calculation. This does not include interest which would be chargeable on any recovery sought. Based upon current advice the Company does not consider any provision is required in relation to this investigation or any other EU State Aid investigation. The assessment of uncertain tax positions is subjective and significant management judgement is required. This judgement is based on current interpretation of legislation, management experience and professional advice.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Interim dividend paid 2019 of £nil per share (2018: £318.62) | - | 6,000 |
| Total ordinary share dividend paid | - | 6,000 |
The Directors do not propose a final dividend (2018: £nil).
| Intellectual | |||
|---|---|---|---|
| property and | |||
| product | |||
| (In £ million) | development | Software | Total |
| Cost | |||
| At 1 October 2018 | - | 73 | 73 |
| Additions | 4 | 9 | 13 |
| Disposals | - | (5) | (5) |
| At 30 September 2019 | 4 | 77 | 81 |
| Accumulated amortisation and impairment | |||
| At 1 October 2018 | - | 18 | 18 |
| Amortisation charge for the year | - | 7 | 7 |
| Disposals | - | (5) | (5) |
| At 30 September 2019 | - | 20 | 20 |
| Net book value | |||
| At 30 September 2019 | 4 | 57 | 61 |
| At 30 September 2018 | - | 55 | 55 |
| Shares in | |
|---|---|
| subsidiary | |
| undertakings | |
| (In £ million) | |
| At 1 October 2018 | 23,746 |
| Additions | 2,447 |
| Impairment | (2,630) |
| Exchange movements | (40) |
| At 30 September 2019 | 23,523 |
During the year, following receipt of a dividend of £2,335m the Company impaired its investment in Imperial Tobacco Management Luxemburg sarl by £2,335 million, and immediately acquired an investment in Imperial Finance Ireland Limited of £2,355 million. The Company also acquired an investment in Imperial Tobacco Ventures Limited of £112 million.
As part of the year end impairment review, the Company has recorded a further impairment in Imperial Tobacco Management Luxembourg sarl of £57 million, and an impairment of £238 million in its investment in Altadis Middle East FZCO. The Directors believe that the carrying value of the investments is supported by their underlying assets.
| Fixtures and | ||||
|---|---|---|---|---|
| Land and | Plant and | motor | ||
| (In £ million) | buildings | machinery | vehicles | Total |
| Cost | ||||
| At 1 October 2018 | - | 15 | 57 | 72 |
| Additions | - | - | 6 | 6 |
| Disposals | - | - | (7) | (7) |
| At 30 September 2019 | - | 15 | 56 | 71 |
| Accumulated depreciation | ||||
| At 1 October 2018 | - | 7 | 49 | 56 |
| Depreciation charge for the year | - | - | 5 | 5 |
| Disposals | - | - | (7) | (7) |
| At 30 September 2019 | - | 7 | 47 | 54 |
| Net book value | ||||
| At 30 September 2019 | - | 8 | 9 | 17 |
| At 30 September 2018 | - | 8 | 8 | 16 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Finished inventories | 34 | 60 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Trade receivables | 48 | 48 |
| Amounts owed by group undertakings | 380 | 285 |
| Prepayments and accrued income | 7 | 9 |
| 435 | 342 |
Amounts owed by group undertakings are unsecured, have no fixed date for repayment and are repayable on demand. Within the £380 million (2018: £285 million), £370 million (2018: £273 million) is denominated in euros.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Trade payables | 17 | 20 |
| Amounts owed to group undertakings | 9,297 | 10,031 |
| Corporation tax | 153 | 162 |
| Other taxes, duties and social security contributions | 421 | 455 |
| Accruals and deferred income | 130 | 97 |
| 10,018 | 10,765 |
Amounts owed to group undertakings are unsecured and due within a year. Within the £9,297 million (2018: £10,031 million), £3,104 million (2018: £3,205 million) is denominated in euros.
The Company is party to a notional cash pooling agreement, which has a net overdraft facility attached to it that is shared amongst the Group companies within the cash pool. The rate of interest that is applied to this overdraft is a margin over base rate and is applied to the main account only.
| (In £ million) | Restructuring | Other | Total |
|---|---|---|---|
| At 1 October 2018 | 9 | 1 | 10 |
| Charged in the year | 3 | 1 | 4 |
| Utilised in the year | (6) | - | (6) |
| Unused amounts reversed | (2) | - | (2) |
| At 30 September 2019 | 4 | 2 | 6 |
| (In £ million) | 2019 | 2018 | |
| Current | 6 | 10 | |
| Non-current | - | - | |
| 6 | 10 |
The restructuring provision relates primarily to the closure of the Nottingham factory, which reflects declining industry volumes in Europe, impacted by tough economic conditions, increasing regulation and excise and growth in illicit trade.
The provision for deferred tax consists of the following deferred tax assets:
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Deferred tax assets due within 12 months | 1 | 1 |
| Deferred tax assets due after more than 12 months | 7 | 12 |
| Deferred tax liabilities due after more than 12 months | (91) | (89) |
| (83) | (76) |
| Excess of | Short-term | |||
|---|---|---|---|---|
| capital | timing | Retirement | ||
| (In £ million) | allowances | differences | benefits | Total |
| At 1 October 2018 | 11 | 2 | (89) | (76) |
| Charged to the income statement | (4) | (1) | (13) | (18) |
| Credited to the statement of comprehensive income | - | - | 11 | 11 |
| At 30 September 2019 | 7 | 1 | (91) | (83) |
| Excess of | Short-term | |||
| capital | timing | Retirement | ||
| (In £ million) | allowances | differences | benefits | Total |
| At 1 October 2017 | 13 | 2 | (52) | (37) |
| Charged to the income statement | (2) | - | (11) | (13) |
| Charged to the statement of comprehensive income | - | - | (26) | (26) |
| At 30 September 2018 | 11 | 2 | (89) | (76) |
The Company participates, together with other Group companies, in a pension scheme for its employees, the Imperial Tobacco Pension Fund (ITPF) (the Scheme), which is of a defined benefit type. The assets of the Scheme are held in trustee administered funds. The Scheme provides retirement benefits primarily on the basis of members' final salary and length of service. As it has not been possible to identify the underlying assets and liabilities attributable to each participating company on a consistent and reasonable basis the Company recognises the entire Scheme in these financial statements as the "sponsoring company" in the Scheme.
The Scheme operates under trust law and is managed and administered by the Trustees on behalf of the members in accordance with the terms of the Trust Deed and Rules and relevant legislation. The Scheme's assets are held by the trust.
Annual increases in benefits in payment are dependent on inflation so the main uncertainties affecting the level of benefits payable under the Scheme are future inflation levels (including the impact of inflation on future salary increases) and the actual longevity of the membership.
The contributions paid to the Scheme are set by the Scheme Actuary every three years. The Scheme Actuary is an external consultant, appointed by the Trustees. Principal factors that the Scheme Actuary will have regard to include the covenant offered by the Company, the level of risk in the Scheme, the expected returns on the Scheme's assets, the results of the funding assessment on an ongoing basis and the expected cost of securing benefits if the fund were to be discontinued.
The latest valuation of the ITPF was carried out as at 31 March 2016 when the market value of the invested assets was £3,302 million. Based on the ongoing funding target the total assets were sufficient to cover 96 per cent of the benefits that had accrued to members for past service, after allowing for expected future pay increases. The total assets were sufficient to cover 90 per cent of the total benefits that had accrued to members for past service and future service benefits for current members. In compliance with the Pensions Act 2004, Imperial Tobacco Limited and the Trustee agreed a scheme-specific funding target, a statement of funding principles and a schedule of contributions accordingly. The ITPF is currently undergoing a valuation as at 31 March 2019, the outcomes of which will be available later in the year.
Following the 2016 valuation, the level of employer's contributions to the scheme was increased from £65 million per year. The Company paid £85 million in the year to 31 March 2019, and agreed to pay £85 million each year for the subsequent 12 years. Further contributions were agreed to be paid by the Company in the event of a downgrade of the Group's credit rating to non-investment grade by either Standard & Poor's or Moody's. In addition, surety guarantees with a total value of £600 million and a parental guarantee with Imperial Brands PLC have been put in place.
The main risk for the Group in respect of the ITPF is that additional contributions are required if the investment returns are not sufficient to pay for the benefits (which will be influenced by the factors noted above). The level of equity returns will be a key determinant of overall investment return. The investment portfolio is also subject to a range of other risks typical of the asset classes held, in particular exposure to equity markets, credit risk on bonds and exposure to the property market.
The IAS 19 liability measurement of the defined benefit obligation (DBO) and the current service cost are sensitive to the assumptions made about future inflation and salary growth levels, as well as the assumptions made about life expectation. They are also sensitive to the discount rate, which depends on market yields on sterling denominated AA corporate bonds. The main differences between the funding and IAS 19 assumptions are a more prudent longevity assumption for funding and a different approach to setting the discount rate. A consequence of the ITPF's investment strategy, with a significant proportion of the assets invested in equities and other return-seeking assets, is that the difference between the market value of the assets and the IAS 19 liabilities may be relatively volatile.
The aggregate IAS 19 position is as follows:
| 2019 2018 |
||||||
|---|---|---|---|---|---|---|
| (In £ million) | DBO | Assets | Total | DBO | Assets | Total |
| At 1 October | (3,380) | 3,902 | 522 | (3,485) | 3,790 | 305 |
| Consolidated income statement (expense)/income | ||||||
| Current service cost | (16) | - | (16) | (21) | - | (21) |
| Past service cost - plan amendments | (3) | - | (3) | - | - | - |
| Cost of termination benefits | (1) | - | (1) | (4) | - | (4) |
| Net interest income/(expense) on net defined | ||||||
| benefit (liability)/asset | (96) | 113 | 17 | (92) | 102 | 10 |
| Administration costs paid from plan assets | - | (3) | (3) | - | (3) | (3) |
| (Cost)/income recognised in the income | ||||||
| statement | (116) | 110 | (6) | (117) | 99 | (18) |
| Remeasurements | ||||||
| Actuarial gain/(loss) due to liability experience | 61 | - | 61 | (28) | - | (28) |
| Actuarial (loss)/gain due to financial | ||||||
| assumption changes | (599) | - | (599) | 89 | - | 89 |
| Return on plan assets excluding amounts | ||||||
| included in net interest income above | - | 473 | 473 | - | 94 | 94 |
| Remeasurement effects recognised in other | ||||||
| comprehensive income | (538) | 473 | (65) | 61 | 94 | 155 |
| Cash | ||||||
| Employer contributions | - | 85 | 85 | - | 80 | 80 |
| Employee contributions | (1) | 1 | - | (1) | 1 | - |
| Benefits paid from plan assets | 155 | (155) | - | 162 | (162) | - |
| Net cash | 154 | (69) | 85 | 161 | (81) | 80 |
| At 30 September | (3,880) | 4,416 | 536 | (3,380) | 3,902 | 522 |
Assets and liabilities recognised on the balance sheet
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Retirement benefit assets | 4,416 | 3,902 |
| Retirement benefit liabilities | (3,880) | (3,380) |
| 536 | 522 |
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Defined benefit costs in operating loss | 23 | 28 |
| Defined contribution costs in operating loss | 4 | 4 |
| Total retirement scheme costs in operating loss | 27 | 32 |
Split as follows in the income statement:
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Cost of sales | - | 1 |
| Distribution, advertising and selling costs | 8 | 9 |
| Administrative and other expenses | 19 | 22 |
| Total retirement scheme costs in operating loss | 27 | 32 |
| (In £ million unless otherwise indicated) | 2019 | 2018 |
|---|---|---|
| Defined benefit obligation | 3,880 | 3,380 |
| Fair value of scheme assets | (4,416) | (3,902) |
| Net defined benefit asset | (536) | (522) |
| Current service cost | 16 | 21 |
| Employer contributions | 85 | 80 |
| Principal actuarial assumptions used (% per annum) | ||
| Discount rate | 1.8 | 2.9 |
| Future salary increases | 3.1 | 3.7 |
| Future pension increases | 3.1 | 3.2 |
| Inflation | 3.1 | 3.2 |
| 2019 | 2018 | |||
|---|---|---|---|---|
| Life expectancy at age 65 years | Male | Female | Male | Female |
| Member currently aged 65 | 22.1 | 23.7 | 22.0 | 23.6 |
| Member currently aged 50 | 23.3 | 25.5 | 23.4 | 25.5 |
Sensitivity analysis is illustrative only and is provided to demonstrate the degree of sensitivity of results to key assumptions. Generally, estimates are made by re-performing calculations with one assumption modified and all others held constant.
| % increase in DBO | 2019 | 2018 |
|---|---|---|
| Discount rate: 0.5% decrease | 9.3 | 8.7 |
| Rate of inflation: 0.5% increase | 7.7 | 7.1 |
| One year increase in longevity for a member currently age 65, | ||
| corresponding changes at other ages | 4.9 | 3.5 |
The sensitivity to the inflation assumption change includes corresponding changes to the future salary increases and future pension increases assumptions, but is assumed to be independent of any change to discount rate.
An approximate split of the major categories of the Scheme assets is as follows:
| 2019 | 2018 | |||
|---|---|---|---|---|
| Percentage | Percentage | |||
| of Scheme | of Scheme | |||
| (In £ million unless otherwise indicated) | Fair value | assets | Fair value | assets |
| Equities | 497 | 11 | 564 | 13 |
| Bonds - index linked government | 1,912 | 43 | 1,403 | 32 |
| Bonds - corporate and other | 666 | 15 | 361 | 8 |
| Property | 563 | 13 | 542 | 12 |
| Absolute return | 732 | 17 | 477 | 11 |
| Other - including derivatives, commodities and cash | 46 | 1 | 555 | 24 |
| Fair value of scheme assets before deferred tax | 4,416 | 100 | 3,902 | 100 |
The primary investment objective is to invest the ITPF's assets in an appropriate and secure manner such that members' benefit entitlements can be paid as they fall due. Specifically the ITPF targets an expected return in excess of the growth in the liabilities, which in conjunction with the contributions paid is consistent to achieve and maintain an ongoing funding level of at least 100 per cent on a buy-out basis by 2028.
The majority of the assets are quoted. Absolute return pooled funds are in overseas, non-quoted assets.
There is now no self-investments in the Imperial Brands PLC shares following termination of the mandates that previously held these shares. As in previous years, the value of ground leases have been allocated to the property asset class.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Authorised, allotted, called up and fully paid | ||
| 18,831,139 ordinary shares of £1 each (2018: 18,831,139) | 19 | 19 |
| 21. Capital commitments | ||
| (In £ million) | 2019 | 2018 |
| Contracted future expenditure but not provided in the financial statements | 125 | 88 |
The Company reviews outstanding legal cases following developments in the legal proceedings at each balance sheet date, considering the nature of the litigation, claim or assessment; the legal processes and potential level of damages in the jurisdiction in which the litigation, claim or assessment has been brought; the progress of the case; the opinions or views of legal counsel and other advisers; experience of similar cases; and any decision of the Group's management as to how it will respond to the litigation, claim or assessment.
To the extent that the Company's assessments at any time do not reflect subsequent developments or the eventual outcome of any claim, its future financial statements may be materially affected, with a favourable or adverse impact upon the Company's operating profit, financial position and liquidity. There are currently no outstanding legal claims.
The Group operates four types of share-based incentive programmes, designed to incentivise staff and to encourage them to build a stake in the Group.
The purpose of the Share Matching Scheme is to encourage eligible employees to acquire and retain Imperial Brands PLC ordinary shares.
Directors and a proportion of the Company's management may elect to invest any proportion of their Share Matching Scheme Eligible Bonus in Imperial Brands PLC ordinary shares to be held by the Employee Benefit Trusts. Provided the shares are left in the Trusts for three years and the individual remains in employment within the Group, the individual will retain the original shares, including dividend roll-up, and receive additional shares on a one-for-one basis.
Annual conditional awards have been made to Directors and other senior executives. The conditional awards, which vest three years after grant, including dividend roll-up, are subject to the satisfaction of specified performance criteria measured over a three year performance period. Further information relating to the performance criteria and the terms of the LTIP are set out in the Annual Report of Imperial Brands PLC.
Under the International Sharesave Plan the Imperial Brands PLC Board may offer options to purchase ordinary shares in Imperial Brands PLC to employees who enter into a savings contract. The price at which options may be offered varies depending on local laws, but will not be less than 80 per cent of the closing mid-market price of an Imperial Brands PLC ordinary share on the London Stock Exchange on the day prior to invitation. The options may normally be exercised during the six months after expiry of the savings contract, three years after entering the Plan.
Under the UK Sharesave Plan, which is part of the Group's International Sharesave Plan, the Imperial Brands PLC Board may offer options to purchase ordinary shares in Imperial Brands PLC to UK employees who enter into an HM Revenue and Customs approved Save as You Earn (SAYE) savings contract. The options may normally be exercised during the six months after the expiry of the SAYE contract, three years after entering the UK Sharesave Plan.
Under the DSAP, one-off conditional awards are made to individuals to recognise exceptional contributions within the business. Awards, which are not subject to performance conditions and under which vested shares do not attract dividend roll-up, will normally vest on the third anniversary of the date of grant subject to the participant's continued employment. The limit of an award under the DSAP is capped at 25 per cent of the participant's salary at the date of grant. Shares used to settle awards under the DSAP will be market purchased.
| (In £ million) | 2019 | 2018 |
|---|---|---|
| Share Matching Scheme | 3 | 6 |
| Long Term Incentive Plan | 11 | 5 |
| Sharesave Plan | 1 | 1 |
| Discretionary Share Awards Plan | 1 | 1 |
| 16 | 13 |
| 2019 | |||||
|---|---|---|---|---|---|
| Sharesave | |||||
| weighted | |||||
| Share | average | ||||
| Thousands of shares unless otherwise | Matching | LTIP | Sharesave | DSAP | exercise price |
| indicated | awards | awards | awards | awards | (£) |
| Outstanding at 1 October 2018 | 424 | 1,539 | 231 | 22 | 24.28 |
| Granted | 66 | 1,091 | 202 | 9 | 17.45 |
| Lapsed/cancelled | (13) | (322) | (169) | (1) | 23.82 |
| Exercised | (237) | (79) | (4) | (9) | 24.41 |
| Outstanding at 30 September 2019 | 240 | 2,229 | 260 | 21 | 19.27 |
| Exercisable at 30 September 2019 | - | - | 13 | - | 29.68 |
| 2018 | |||||
| Sharesave | |||||
| weighted | |||||
| Share | average | ||||
| Thousands of shares unless otherwise | Matching | LTIP | Sharesave | DSAP | exercise |
| indicated | awards | awards | awards | awards | price (£) |
| Outstanding at 1 October 2017 | 685 | 886 | 254 | 22 | 27.15 |
| Granted | 66 | 984 | 162 | 2 | 22.24 |
| Lapsed/cancelled | |||||
| Exercised | (53) (274) |
(204) (127) |
(97) (88) |
(1) (1) |
23.51 29.10 |
The weighted average Imperial Brands PLC share price at the date of exercise of awards and options was £25.96 (2018: £28.96). The weighted average fair value of Sharesave options granted during the year was £3.54 (2018: £4.37).
Exercisable at 30 September 2018
| Number of | Vesting | Exercise price | |
|---|---|---|---|
| awards/ | period | of options | |
| options | remaining in | outstanding | |
| Thousands of shares unless otherwise indicated | outstanding | months | (£) |
| Share Matching Scheme | |||
| 2017 | 173 | 5 | n/a |
| 2018 | 33 | 17 | n/a |
| 2019 | 34 | 29 | n/a |
| Total awards outstanding | 240 |
| Summary of awards/options outstanding at 30 September 2019 (continued) | Number of | ||
|---|---|---|---|
| awards/ | Vesting period | Exercise price of | |
| options | remaining in | options | |
| Thousands of shares unless otherwise indicated | outstanding | months | outstanding (£) |
| Long Term Incentive Plan | |||
| 2015 | 9 | - | n/a |
| 2016 | 2 | - | n/a |
| 2017 | 274 | 5 | n/a |
| 2018 | 888 | 17 | n/a |
| 2019 | 1,056 | 29 | n/a |
| Total awards outstanding | 2,229 | ||
| Sharesave Plan | |||
| 2016 | 13 | - | 29.68 |
| 2017 | 11 | 10 | 29.62 |
| 2018 | 36 | 22 | 22.24 |
| 2019 | 200 | 34 | 17.45 |
| Total awards outstanding | 260 | ||
| Discretionary Shares Awards Plan | |||
| 2017 | 10 | 8 | n/a |
| 2018 | 2 | 19 | n/a |
| 2019 | 9 | 29 | n/a |
| Total awards outstanding | 21 |
The vesting period is the period between the grant of awards or options and the earliest date on which they are exercisable. The vesting period remaining and the exercise price of options outstanding are weighted averages. Participants in the Sharesave Plan have six months from the maturity date to exercise their option. Participants in the LTIP have up to seven years from the end of the vesting period to exercise their option. The exercise price of the options is fixed over the life of each option.
For the purposes of valuing options to calculate the share-based payment charge, the Black-Scholes option pricing model has been used for the Share Matching Scheme, Sharesave Plan and Discretionary Awards Plan. A summary of the assumptions used in the Black-Scholes model for 2019 and 2018 is as follows:
| 2019 | |||
|---|---|---|---|
| Share | |||
| matching | Sharesave | DSAP | |
| Risk-free interest rate | 1.1% | 1.1% | 0.7% - 1.1% |
| Volatility | 25.0% | 24.4% | 24.7% - 26.3% |
| Expected lives of options granted | 3 yrs | 3 yrs | 3 yrs |
| Dividend yield | 6.7% | 6.7% | 6.7% |
| Fair value | £21.72 | £3.54 | £15.65 - £21.72 |
| Share price used to determine exercise price | £26.52 | £21.81 | £18.69 - £26.52 |
| Exercise price | n/a | £17.45 | n/a |
| 2018 | ||||
|---|---|---|---|---|
| Share | ||||
| matching | Sharesave | DSAP | LTIP | |
| Risk-free interest rate | 1.2% | 1.2% | 1.2% | 1.2% - 1.3% |
| Volatility | 24.1% | 24.2% | 24.2% | 23.9 - 24.5% |
| Expected lives of options granted | 3 yrs | 3 yrs | 3 yrs | 3 - 5 yrs |
| Dividend yield | 4.8% | 4.8% | 4.8% | 4.8% |
| Fair value | £22.84 | £4.37 | £24.24 | £22.05 - £24.24 |
| Share price used to determine exercise price | £26.34 | £26.32 | £27.96 | £27.96 |
| Exercise price | n/a | £22.24 | n/a | n/a |
Market conditions were incorporated into the Monte Carlo method used in determining the fair value of LTIP awards at grant date. Assumptions in 2019 and 2018 are given in the following table.
| (%) | 2019 | 2018 |
|---|---|---|
| Future Imperial Tobacco Group share price volatility | 20 | 18.7 - 19.2 |
| Future Imperial Tobacco Group dividend yield | - | - |
| Share price volatility of the tobacco and alcohol comparator group | 14.9 - 65.6 | 17.0 - 38.0 |
| Correlation between Imperial Tobacco and the alcohol and tobacco | ||
| comparator group | 27 | 32 |
The Company has taken advantage of the Group exemption under the terms of IAS 24 from disclosing related party transactions with entities that are part of the Group since the Company is a wholly owned subsidiary of Imperial Brands PLC and is included in the consolidated financial statements of the Group, which are publicly available.
Together with Imperial Brands PLC (IB) (the ultimate parent company), the Company acts as guarantor for the following facilities for the benefit of the overall IB Group; one committed credit facility dated April 2019; bonds issued since September 2008 under various Euro Medium Term Noted Debt Issuance Programmes; bonds issued since February 2013 under the provisions of Sections 144 and Regulation S of the US Securities Act (1933); four uncommitted credit borrowing facilities dated March 2011, May 2017, August 2017 and November 2018; International Swap and Derivatives Association agreement dated March 2012. In addition, the Company also acts as a guarantor together with IB and various other subsidiaries of IB for an uncommitted borrowing facility dated January 2007.
At 30 September 2019, the contingent liabilities totalled £16,753 million (2018: £14,323 million).
The Directors have assessed the fair value of the above guarantees and do not consider them to be material. They have, therefore, not been recognised on the balance sheet.
In March 2020 the Imperial Brands Group was impacted by the global Coronavirus (Covid-19) pandemic, which resulted in unprecedented government restrictions on the normal operations of the Group across many countries. The restrictions put in place initially resulted in a number of office and factory closures. The Group has responded by adapting working practices through activities such as strengthening our IT infrastructure and accelerating the rollout of software to remote facilitate team-working, as well as encouraging a more flexible approach. There have been modifications to working practices including changing shift patterns to ensure appropriate infection controls and social distancing for employees in manufacturing facilities. As a result of this, manufacturing plants have continued to operate and the Group is able to both produce and distribute product to customers to meet demand, while complying with all necessary safety precautions to protect staff and business partners from the risks arising from the pandemic.
As the pandemic commenced in 2020 this represents a non adjusting post balance sheet event with regards to the financial statements of the Company for the year ending 30 September 2019.
To date, the observable impacts on the Company's activities have been limited to low level changes in credit risk in the duty free and travel retail operations area. The Company is not aware of any post year end impairments to its investments specifically associated with the impact of the pandemic.
Review of the key financial assumptions relating to the Company's defined benefit pension scheme subsequent to the balance sheet date indicates that the fair value of plan assets is expected to be volatile in the short term due to uncertain market conditions.
The ultimate parent undertaking and controlling party of the Company at 30 September 2019 was Imperial Brands PLC, a company incorporated in the United Kingdom and registered in England and Wales. The smallest and largest group in which the results of the Company are consolidated is that headed by Imperial Brands PLC, whose consolidated financial statements may be obtained from the Company Secretary, 121 Winterstoke Road, Bristol, BS3 2LL.
The immediate parent undertaking of Imperial Tobacco Limited at 30 September 2019 was Imperial Tobacco Holdings Limited, a company incorporated in the United Kingdom and registered in England and Wales.
In accordance with Section 409 of the Companies Act 2006 a full list of subsidiaries, partnerships, associates, and joint ventures, the principal activity, the country of incorporation and the effective percentage of equity owned, as at 30 September 2019 are disclosed below.
| Name | Principal activity and registered address |
|---|---|
| Imperial Tobacco Overseas | Holding investments in subsidiary companies |
| Holdings (3) Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Imperial Tobacco Overseas | Holding investments in subsidiary companies |
| Holdings Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Imperial Tobacco Overseas | Holding investments in subsidiary companies |
| Limited (x) | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Imperial Tobacco Pension | Dormant |
| Trustees (Burlington House) | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Limited Imperial Tobacco Pension | Dormant |
| Trustees Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Imperial Tobacco Ventures | Holding investments in subsidiary companies |
| Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| ITG Brands Limited | Holding investments in subsidiary companies |
| 121 Winterstoke Road, Bristol, BS3 2LL, England | |
| Joseph & Henry Wilson Limited | Licencing rights for the manufacture and sale of tobacco |
| products | |
| Nerudia Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England Research and development of e-vapour products |
| Wellington House, Physics Road, Speke, Liverpool, L24 9HP, | |
| England | |
| Nerudia Trading Limited | Dormant |
| Wellington House, Physics Road, Speke, Liverpool, L24 9HP, | |
| England | |
| Nerudia Consulting Limited | Research and development of e-vapour products |
| Wellington House, Physics Road, Speke, Liverpool, L24 9HP, | |
| England | |
| Nerudia Compliance Limited | Dormant |
| Wellington House, Physics Road, Speke, Liverpool, L24 9HP, | |
| England | |
| Park Lane Tobacco Company | Dormant |
| Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Rizla UK Limited | Entity ceased trading |
| 121 Winterstoke Road, Bristol, BS3 2LL, England | |
| Sensus Investments Limited | Dormant |
| Wellington House, Physics Road, Speke, Liverpool, L24 | |
| 9HP, England | |
| Sinclair Collis Limited (iv) | Dormant Distributor of tobacco products in England, Scotland |
| and Wales | |
| 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| 1213509 B.C. Limited | Canada | Holding investments in subsidiary companies |
| Suite 1700. Park Place, 666 Burrard Street, Vancouver, BC. | ||
| V6C2X8, Canada | ||
| 800 JR Cigar Inc | United States of | Holding investments in subsidiary companies |
| America | 301 Route 10 East, Whippany, New Jersey, 07981, USA | |
| Altadis Canarias SAU (ii) | Spain | Marketing and sale of tobacco products in the Canary Islands |
| C/Comandaute Azcarraga 5, Madrid 28016, Spain | ||
| Altadis Mayotte SAS | France, Mayotte | Sales and distribution of tobacco products in Mayotte Island |
| Island | C/o SOMACO, BP 15 - Mamoudzou, 97600, Mayotte | |
| Altadis Middle East FZCO | United Arab | Sales and marketing of tobacco products in the Middle East |
| Emirates | P.O. Box. No. 261718, Jebel Ali Free Zone, Dubai, 261718, | |
| United Arab Emirates | ||
| Altadis Ocean Indien SAS | France (La Reunion | Sales and distribution of tobacco products in la Reunion Island |
| Island) | ZI n° 2 - BP 256 - 97457 Saint Pierre Cedex, La Reunion | |
| Altadis S.A.U. | Spain | Manufacture, sales and distribution of tobacco products in |
| Spain | ||
| Parque Empresarial Cristalia, Vía de los Poblados, 3, Edificio | ||
| 7/8, Madrid, 28033, Spain | ||
| Cacique, SA - Comércio, | Brazil | Dormant |
| Importaçao e Exportaçao | Rua Marechal Deodoro, 690 - Centro Arapiraca, Alagoas, Brazil | |
| Casa Blanca Inc | United States of | Restaurant |
| America | 301 Route 10 East, Whippany, New Jersey, 07981, USA | |
| Casa de Montecristo Inc | United States of | Retail |
| America | Corporation Service Company, 2711 Centerville Road, Suite | |
| 400, City of Wilmington, County of New Castle, DE, 19808, USA | ||
| Casa de Montecristo FL LLC | United States of | Retail |
| America | C/o Corporation Service Company, 1201 Hayes Street, | |
| Tallahassee Florida 32301, USA | ||
| Casa de Montecristo TN LLC | United States of | Retail |
| America | CSC, 2908 Poston Avenue, Nashville, TN 37203, USA | |
| Casa de Montecristo TX LLC | United States of | Retail |
| America | Corporate Service Company, 211 E. 7th Floor, Suite 260, Austin, | |
| Texas, TX 78701, USA | ||
| Coralma International SAS | France | Holding investments in subsidiary companies |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | ||
| Dunkerquoise des Blends SAS | France | Tobacco processing |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| East Side Cigar, Inc | United States of | Production and distribution of cigars |
| America | Corporate Service Company, 80 State St, Albany, NY12207- | |
| 2543, USA | ||
| Ets L Lacroix Fils NV/SA | Belgium | Manufacture and sale of tobacco products in Belgium |
| Sint-Bavostraat 66, 2610 Wilrijk, Belgium | ||
| Fontem (Beijing) Technology | People's Republic | Research and development |
| Solutions Limited (i) | of China | Room 201, Floor 2, Building 6, Yuan Dong science and |
| technology park, 6 Hepingli North Street, Dong Cheng District, | ||
| Beijing, 100013, China | ||
| Fontem Canada Limited (vii) | Canada | Import and distribution of tobacco and tobacco related |
| products in Canada | ||
| Suite 200, 389 Connell Street, Woodstock, NB, E7M 5G5, | ||
| Canada | ||
| Fontem Holdings 1 B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem Holdings 2 B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem Holdings 3 B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem Holdings 4 B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem Holdings B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem International GmbH | Germany | Holding investments in subsidiary companies |
| Max-Born-Straße 4, Hamburg, 22761, Germany | ||
| Fontem US, Inc. | United States of | Sales and marketing of tobacco products in the US |
| America | 4th Floor, 3730 Glen Lake Dr. Charlotte, NC 28208, USA | |
| Fontem Ventures B.V. | The Netherlands | Holding investments in subsidiary companies |
| Radarweg 60, Amsterdam, 1043 NT, The Netherlands | ||
| Fontem Ventures France S.A.S. | France | Marketing and sale of e-vapour products in France |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | ||
| Huotraco International Limited | Cambodia | Production and marketing of tobacco products |
| No 299, Preah Ang Duong Street, Sangkat Wat Phnom, Khan | ||
| Daunh Penh, Phnom Penh, Cambodia | ||
| Import and distribution of tobacco and tobacco related | ||
| Imperial Brands Columbia SAS | Columbia | products in Columbia TV21 No. 98 05, Bogata D.C. Columbia |
| Imperial Brands Finance France | France | Provision of finance to other Group companies |
| SAS | 143 bd Romain Rolland, Cedex 14, Paris, 75685, France |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| Imperial Brands Finland Oy | Finland | Sales and marketing of tobacco products in Finland |
| Poikluomantie 1-3, Piispanristi, 20760, Finland | ||
| Imperial Brands Global Duty | Spain | Sale and export of duty-free tobacco products |
| Free & Export S.L. | C/Comandaute Azcarraga 5, Madrid 28016, Spain | |
| Imperial Finance Ireland Limited Ireland | Provision of finance to other Group Companies 21, | |
| Beckett Way, Park West, Nangor Road, Dublin, 12, | ||
| Ireland | ||
| Imperial Nominees Limited (ii) | New Zealand | Trustee Company |
| 124-130, Richmond Street, Petone, Wellington, New Zealand | ||
| Imperial Tobacco (Asia) Pte. Ltd. Singapore | Trading of tobacco related products | |
| 80 Robinson Road, #02-00, 068898, Singapore | ||
| Imperial Tobacco (Beijing) | People's Republic | Dormant |
| Limited (i) | of China | Rm. 305 D-3F, Vantone Center, Jia No. 6 Chaowai Street, |
| Chaoyang District, Beijing, PRC 100020, China | ||
| Imperial Tobacco Australia | Australia | Sales and marketing of tobacco products in Australia |
| Limited | John Player Special House, Level 4, 4-8 Inglewood Place, | |
| Norwest, NSW 2153, Australia | ||
| Imperial Tobacco Austria | Austria | Marketing of tobacco products in Austria |
| Marketing Service GmbH | Zieglergasse 6, A-1070 Vienna, Austria | |
| Imperial Tobacco BH doo (i) | Bosnia | Marketing and distribution of tobacco products in Bosnia |
| Herzegovina | Adema Buce, Sarajevo, 71000, Bosnia & Herzegovina | |
| Imperial Tobacco Bulgaria | Bulgaria | Manufacture and sale of tobacco products in Bulgaria |
| EOOD (i) | 15 Henrih Ibsen str, Floor 4, Office 4, Sofia, 1407, Bulgaria | |
| Imperial Tobacco CR s.r.o. | Czech Republic | Sales and marketing of tobacco products in the Czech Republic |
| Radlicka 14, Prague 5, 150 00, Czech Republic | ||
| Imperial Tobacco Denmark ApS | Denmark | In liquidation |
| Lyskaer 3 CD, 2730 Herlev, Denmark | ||
| Imperial Tobacco Distribution | Bulgaria | Marketing and distribution of tobacco products in Bulgaria |
| EOOD (i) | 15 Henrih Ibsen str, Floor 4, Office 4, Sofia, 1407, Bulgaria | |
| Imperial Tobacco Distribution | Romania | Marketing and distribution of tobacco products in Romania |
| Romania srl | Nicolae Canea Street no. 140-160, EOS Business Park, 1st Floor | |
| North, 2nd District, Bucharest, Romania | ||
| Imperial Tobacco España, S.L.U. Spain | Holding investments in subsidiary companies | |
| C/Comandaute Azcarraga 5, Madrid 28016, Spain | ||
| Imperial Tobacco Estonia OÜ | Estonia | Sale of tobacco products |
| Valge 13, 11145, Tallinn, Estonia | ||
| Imperial Tobacco Holdings | The Netherlands | Provision of finance to other Group companies |
| (Netherlands) B.V. | Slachtedijk 28a, 8501 ZA, Joure, Netherlands |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| Imperial Tobacco Intellectual | Ireland | Ownership of trademarks |
| Property Limited | 21, Beckett Way, Park West, Nangor Road, Dublin, 12, Ireland | |
| Imperial Tobacco International | Germany | Export and marketing of tobacco products |
| GmbH | Max-Born-Straße 4, Hamburg, 22761, Germany | |
| Imperial Tobacco Ireland | Ireland | Dormant |
| Unlimited Company (v) | 6th Floor, 2 Grand Canal Square, Dublin 2, Ireland | |
| Imperial Tobacco Italia S.r.l. | Italy | Sales and marketing of tobacco products in Italy |
| Via Luca Passi 22, Roma, 00166, Italy | ||
| Imperial Tobacco Italy S.r.l. | Italy | Holding investments in subsidiary companies |
| Via Luca Passi 22, Roma, 00166, Italy | ||
| Imperial Tobacco Japan | Japan | Sales and marketing of tobacco products in Japan |
| Kabushiki Kaisha | 5-12-7 Shirokane dai, M6 Shirokane dai Building, Minato-ku, | |
| Tokyo, Japan | ||
| Imperial Tobacco Korea Limited | Korea | Sales and marketing of tobacco products in South |
| Korea. 612 ho 6F ChosunNaewha BD, 577 Seolleung | ||
| RO, Gangnam-gu, 06143 Republic of Korea | ||
| Imperial Tobacco Magyarország | Hungary | Sales and marketing of tobacco products in Hungary |
| Dohányforgalmázo Kft (Imperial | Váci út 141, 1138, Budapest, Hungary | |
| Tobacco Hungary) | ||
| Imperial Tobacco Management | Luxembourg | Holding investments in subsidiary companies |
| Luxembourg sarl | 56 Rue Charles Martel, L-2134, Luxembourg | |
| Imperial Tobacco Marketing | Malaysia | Trading of tobacco products |
| Sdn Bhd | Symphony Corporatehouse SdnBhd, Level 8 Symphony House, | |
| Block D13, Pusat Dagangan Dana 1, Jalan PJU 1A/46, 47301 | ||
| Petaling Jaya, Selangor Darul Ehsan, Malaysia | ||
| Imperial Tobacco New Zealand | New Zealand | Manufacture and sale of tobacco products in New Zealand |
| Limited | 124-130, Richmond Street, Petone, Wellington, New Zealand | |
| Imperial Tobacco Norway AS | Norway | Sales and marketing of tobacco products in Norway |
| Ryensvingen 2-4, 0680, Oslo, Norway | ||
| Imperial Tobacco Polska | Poland | Manufacture of tobacco products in Poland |
| Manufacturing SA | Ul. Tytoniowa 2/6, Radom, 26-600, Poland | |
| Imperial Tobacco Polska S.A. | Poland | Manufacture and sale of tobacco products in Poland |
| Jankowice, ul. Przemyslowa 1, Pl-62-080, Tarnowo-Podgome, | ||
| Poland | ||
| Imperial Tobacco Portugal | Portugal | Advertising and support management |
| SSPLC | 144, 7 DT, Avenida da Liberdade, Lisbon, Portugal | |
| Imperial Tobacco Production | Ukraine | Manufacture of tobacco products in Ukraine |
| Ukraine (i) | ul. Akademika Zabolotnogo, 35, 03026, Kiev, Ukraine |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| Imperial Tobacco Sales & | Russia | Sales and marketing of tobacco products in Russia |
| Marketing LLC | Degtjarnyi pereulok 4-1, 125009 Moskau, Russian Federation | |
| Imperial Tobacco SCG doo | Serbia | Marketing and distribution of tobacco products in Serbia |
| Beograd (i) | Milutina Milankovica 11a, Novi Beograd, Serbia | |
| Imperial Tobacco Sigara ve | Turkey | Manufacture of tobacco products in Turkey |
| Tutunculuck Sanayi Ve Ticaret | Kecilikoy OSB, Mah. Ahmet Tutuncuoglu Cad. No: 11, 45030 | |
| A.S. | Yunusemre, Manisa, Turkey | |
| Imperial Tobacco Slovakia a.s. | Slovak Republic | Sales and marketing of tobacco products in the Slovak Republic 7A Galvaniho, 824 53 Bratislava, Slovakia |
| Imperial Tobacco Taiwan Co | Taiwan | Sales and marketing of tobacco products in Taiwan |
| Limited | 6F 1-2 No.2 Sec 3, Minsheng E Road, Zhongshen District, Tapei, | |
| Taiwan Province of China | ||
| Imperial Tobacco Taiwan | Taiwan | Manufacture of tobacco products in Taiwan |
| Manufacturing Company | No 8 Cyunyi Road, Jhunan, MiaoLi County 350, Taiwan Province | |
| Limited | of China | |
| Imperial Tobacco Tutun | Turkey | Sales and marketing of tobacco products in Turkey |
| Urunleri Satis Ve Pazarlama A.S. | Kecilikoy OSB, Mah. Ahmet Tutuncuoglu Cad. No: 11, 45030 | |
| Yunusemre, Manisa, Turkey | ||
| Imperial Tobacco Ukraine (i) | Ukraine | Sales and marketing of tobacco products in Ukraine |
| ul. Akademika Zabolotnogo, 35, 03026, Kiev, Ukraine | ||
| Imperial Tobacco Volga LLC (i) | Russia | Manufacture of tobacco products in Russia |
| ul.Tomskaja 7, 400048 Volgograd, Russian Federation | ||
| Imperial Tobacco West Africa | Cote D'Ivoire | Holding investments in subsidiary companies |
| SAS (i) | Cocody-Nord, Quartier Gendarmerie, TF 5937, 01 B.P. 724 | |
| Abidjan | ||
| Imperial Tobacco Yaroslavl CJSC | Russia | Manufacture of tobacco products in Russia |
| (i) | 22, Pobedy St., 150040 Yaroslavl, 150040, Russian Federation | |
| Imperial Tobacco Zagreb doo (i) | Croatia | Marketing and distribution of tobacco related products in |
| Croatia | ||
| Gradičanska 30, Zagreb, HR-10000, Croatia | ||
| IMPTOB South Africa (Pty) | South Africa | Provision of services to other Group companies |
| Limited | Suite 107, Beacon Rock, 21 Lighthouse Road, Umhlanga 4319, | |
| South Africa | ||
| International Marketing | Nigeria | Sales and marketing and of tobacco products in Nigeria |
| Promotional Services Limited | 13 A, Dapo Solanke Close - Lekki Phase 1, Lagos, Nigeria | |
| ITB Corporation Limited | Bahamas | Trademark owner |
| Building of the Canadian Imperial Bank of Commerce, Shirley | ||
| Street, Nassau, Bahamas |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| ITB Corporation y Cía., S.R.C. | Spain | Trademark owner |
| Calle Antonio Maura número 9, Madrid, 28014, Spain | ||
| ITI Cigars SL | Spain | Holding investments in subsidiary companies |
| Parque Empresarial Cristalia, Vía de los Poblados, 3, Edificio | ||
| 7/8, Madrid, 28033, Spain | ||
| ITL Pacific (HK) Limited | Hong Kong | Manufacture and sale of tobacco and tobacco related products |
| Room 3907-08, 39th Floor, Hopewell Centre, 183 Queens Road | ||
| East, Wanchai, Hong Kong | ||
| J & R Tobacco (New Jersey) | United States of | Sales of tobacco and tobacco related products |
| Corp | America | 301 Route 10 East, Whippany, New Jersey, 07981, USA |
| JAW-Invest Oy | Finland | Trademark owner |
| Poikluomantie 1-3, Piispanristi, 20760, Finland | ||
| John Player & Sons Limited | Ireland | Sales and marketing of tobacco products in the Republic of |
| Ireland | ||
| 21, Beckett Way, Park West, Nangor Road, Dublin, 12, Ireland | ||
| John Player Ireland Pension | Ireland | Sales and marketing of tobacco products in the Republic of |
| Trustee Limited | Ireland | |
| 21, Beckett Way, Park West, Nangor Road, Dublin, 12, Ireland | ||
| JR Cigar (DC) Inc | United States of | Sales of tobacco and tobacco related products |
| America | 301 Route 10 East, Whippany, New Jersey, 07981, USA | |
| JR Cigars.com, Inc. | United States of | Sales of tobacco and tobacco related products |
| America | 405 East Market Street, P.O. Drawer 1960, Smithfield, North | |
| Carolina, 27577, USA | ||
| JR Mooresville, Inc | United States of | Sales of tobacco and tobacco related products |
| America | 405 East Market Street, P.O. Drawer 1960, Smithfield, North | |
| Carolina, 27577, USA | ||
| JR Tobacco NC, Inc | United States of | Sales of tobacco and tobacco related products |
| America | 405 East Market Street, P.O. Drawer 1960, Smithfield, North | |
| Carolina, 27577, USA | ||
| JR Tobacco of America Inc | United States of | Sales of tobacco and tobacco related products |
| America | 327, Hillsborough Street, Raleigh, NC, 27603, USA | |
| JR Tobacco of Burlington Inc | United States of | Sales of tobacco and tobacco related products |
| America | 327, Hillsborough Street, Raleigh, NC, 27603, USA | |
| JR Tobacco of Michigan Inc | United States of | Sales of tobacco and tobacco related products |
| America | 601, Abbott Road, East lansing, Ingham, MI, 48823, USA | |
| JR Tobacco Outlet Inc | United States of | Sales of tobacco and tobacco related products |
| America | 301 Route 10 East, Whippany, New Jersey, 07981, USA | |
| JSNM SARL | France | Trademark owner |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| La Flor de Copan Honduras SA | Honduras (CA) | Manufacture of handmade premium cigars |
| Zona Libre, Colonia MeJia Garcia, Frente Boulavard, Jorge | ||
| Bueso Arias, Santa Rosa de Copan, Honduras | ||
| Los Olvidados SRL | Dominican | Manufacture and distribution of cigars |
| Republic | 129, Independencia Street, Santiago, 51000, Dominican | |
| Republic | ||
| MYBLU Spain S.L. | Spain | Marketing and sale of e-vaopur products in Spain |
| CR. Robledo de Chavela, S/N. San Lorenzo del Escorial, Madrid, | ||
| 28200, Spain | ||
| MC Management, Inc. | United States of | Provision of services to other Group companies |
| America | 301 Route 10 East, Whippany, New Jersey, 07981, USA | |
| Meccarillos France, SA | Luxembourg | Holding investments in subsidiary companies |
| Route Des Trois Cantons 9, 8399 Windhof, Luxembourg | ||
| Meccarillos International, SA | Luxembourg | Holding investments in subsidiary companies |
| Route Des Trois Cantons 9, 8399 Windhof, Luxembourg | ||
| Meccarillos Suisse, SA | Luxembourg | Holding investments in subsidiary companies |
| Route Des Trois Cantons 9, 8399 Windhof, Luxembourg | ||
| Millennium Tobacco Unlimited | Ireland | Provision of finance to other Group companies |
| Company | 21, Beckett Way, Park West, Nangor Road, Dublin, 12, Ireland | |
| Newglade International | Ireland | Dormant |
| Unlimited Company | 6th Floor, 2 Grand Canal Square, Dublin 2, Ireland | |
| Philippine Bobbin Corporation | Philippines | Manufacture of tobacco related products |
| Cavite Economic Zone, Phase II, Rosario, Cavite, Philippines | ||
| Real Club de Golf la Herrería | Spain | Management of golf course |
| S.A. | CR. Robledo de Chavela, S/N. San Lorenzo del Escorial, Madrid, | |
| 28200, Spain | ||
| REEMARK Gesellschaft für | Germany | Dormant |
| Markenkooperation mbH | Max-Born-Straße 4, Hamburg, 22761, Germany | |
| Robert Burton Associates | United States of | Marketing of papers in the US |
| Limited | America | 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, |
| Florida, FL 33309, USA | ||
| Santa Clara Inc | United States of | Distribution of cigars |
| America | 327, Hillsborough Street, Raleigh, NC, 27603, USA | |
| Skruf Snus AB | Sweden | Manufacture, marketing, sales of tobacco products in Sweden |
| Kungsgatan 12-14, Floor 7, Stockholm, SE-111 35, Sweden | ||
| Société Centrafricaine de | Central African | Manufacture and distribution of cigarettes in Central African |
| Cigarettes SA (i) | Republic | Republic |
| Rue David Dacko, BP 1446, Bangui, Central African Republic |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| Société Centrafricaine de | Central African | Dormant |
| Distribution Sarl (i) | Republic | Avenue Boganda Pk4, Bangui, Central African Republic |
| Société du Mont Nimba Sarl (i) | Guinee Conakry | Dormant |
| BP 3391, Conakry, Guinea | ||
| Société Nationale d'Exploitation | France | Manufacture and sale of tobacco products in France, and |
| Industrielle des Tabacs et | export of tobacco products | |
| Allumettes SAS (SEITA) | 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | |
| Société pour le Développement | France | Purchasing company |
| du Tabac en Afrique SAS | 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | |
| System Designed to Africa Sarl | Morocco | Distribution of tobacco products |
| Km 17, Route national de Rabat, Ain Harrouda, Morocco | ||
| Tabacalera Brands SLU | Spain | Holding investments in subsidiary companies |
| Parque Empresarial Cristalia, Vía de los Poblados, 3, Edificio | ||
| 7/8, Madrid, 28033, Spain | ||
| Tabacalera de Garcia SAS | France | Manufacture of cigars in the Dominican Republic |
| 320, Rue Saint-Honore, Paris, 75001, France | ||
| Tabacalera de Garcia SAS | Dominican | Manufacture of cigars in the Dominican Republic |
| Republic | Industrial Free Zone #1, La Romana, Domincan Republic | |
| Tabacalera SLU | Spain | Holding investments in subsidiary companies |
| C/Via de los Poblados, 3 Edif. 7-8, Plantas 3a y 4a, Madrid, | ||
| 28033, Spain | ||
| Tabacalera USA Inc | United States of | Holding investments in subsidiary companies |
| America | Corporation Service Company, 2711 Centerville Road, Suite | |
| 400, City of Wilmington, County of New Castle, DE, 19808, USA | ||
| Tahiti Tabacs SASU | France, Papeete | Distribution of tobacco products in Denmark and Greenland |
| (Tahiti) | PK 4, 300 Côté mer, 98701 Arue, BP 20692 Papeete, French | |
| Polynesia | ||
| Tobacco Products Fulfillments, | United States of | Fulfilment services |
| Inc. | America | PK 4, 300 Côté mer, 98701 Arue, BP 20692 Papeete, French |
| Polynesia | ||
| Tobaccor SAS (v) | France | Holding investments in subsidiary companies |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | ||
| Tobačna 3DVA, trgovsko | Slovenia | Retail of products in Slovenia |
| podjetje, d.o.o. | Cesta 24., junija 90, SI 1231 Ljubljana - Ĉrnuče, Slovenia | |
| Tobačna Grosist d.o.o. | Slovenia | Marketing and distribution in Slovenia |
| Cesta 24., junija 90, SI 1231 Ljubljana - Ĉrnuče, Slovenia | ||
| Tobačna Ljubljana d.o.o. (v) | Slovenia | Sales and marketing tobacco products in Slovenia |
| Cesta 24., junija 90, SI 1231 Ljubljana - Ĉrnuče, Slovenia |
| Country of | ||
|---|---|---|
| Name | incorporation | Principal activity and registered address |
| Tobamark International SA | France | Trademark owner |
| 143 bd Romain Rolland, Cedex 14, Paris, 75685, France | ||
| Urex Inversiones SA | Spain | Holding investments in subsidiary companies |
| Parque Empresarial Cristalia, Vía de los Poblados, 3, Edificio 7/8, | ||
| Madrid, 28033, Spain | ||
| Universal Brands, S.A. | Spain | Trademark owner |
| C/Comandaute Azcarraga 5, Madrid 28016, Spain | ||
| Van Nelle Tabak Nederland B.V. | The Netherlands | Manufacture and sale of tobacco products in the Netherlands |
| (x) | Slachtedijk 28a, 8501 ZA, Joure, Netherlands | |
| Van Nelle Tobacco International | The Netherlands | Sale of tobacco and tobacco related products |
| Holdings B.V. | Slachtedijk 28a, 8501 ZA, Joure, Netherlands | |
| West Park Tobacco Inc. | United States of | In Dissolution |
| America | c/o CT Corporation System, 4701 Cox Road, Ste 301,Glen | |
| Allen/Richmond, VA 23060-6802, USA |
| % | ||
|---|---|---|
| Name | Principal activity and registered address | owned |
| Congar International UK Limited | Dormant | 63.1 |
| 121 Winterstoke Road, Bristol, BS3 2LL, England | ||
| Imperial Brands Enterprise | Provison of treasury services to other Group companies | 42.0 |
| Finance Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England | |
| Imperial Tobacco Overseas | Holding investments in subsidiary companies | 42.0 |
| Holdings (4) Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England | |
| La Flor de Copan UK Limited | Holding investments in subsidiary companies | 63.1 |
| 121 Winterstoke Road, Bristol, BS3 2LL, England | ||
| Tabacalera de Garcia UK | Holding investments in subsidiary companies | 63.1 |
| Limited | 121 Winterstoke Road, Bristol, BS3 2LL, England |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Altadis Holdings USA Inc | United States of | Holding investments in subsidiary companies | 63.1 |
| America | 5900 North Andrews Avenue, Ste. 1100, Fort | ||
| Lauderdale, FL, 33309, USA | |||
| Altadis Management Services | United States of | Trademark service company | 63.1 |
| Corporation | America | 5900 North Andrews Avenue, Ste. 1100, Fort | |
| Lauderdale, FL, 33309 USA |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Altadis Retail Corporation | United States of America |
Trademark owner 300 Delaware Avenue, Ste. 1230, Wilmington, DE, 19801, USA |
63.1 |
| Altadis Shade Company LLC | United States of America |
Manufacture and sale of tobacco products in the USA 217 Shaker Road, Somers, CT, 06071, USA |
63.1 |
| Altadis USA Inc | United States of America |
Manufacture and sale of cigars in the USA 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309, USA |
63.1 |
| CBHC Inc | United States of America |
Dormant 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309 USA |
63.1 |
| CdM Hallandale, LLC | United States of America |
TBC c/o Corporation Service Company, 1201 Hays Street, Tallahassee, Florida, 32301, USA |
50.0 |
| Cigar Savor Enterprises LLC | United States of America |
Manufacture of tobacco products 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309 USA |
63.1 |
| Commonwealth Brands Inc | United States of America |
Manufacture and sale of tobacco products in the USA 301 N. Scales Street, Reidsville, North Carolina, NC27320 USA |
63.1 |
| Commonwealth-Altadis, Inc | United States of America |
Sales and distribution of tobacco products in the USA 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309 USA |
63.1 |
| Compagnie Agricole et Industrielle des Tabacs Africains SAS |
France | Management company 143 bd Romain Rolland, Cedex 14, Paris, 75685, France |
99.9 |
| Compagnie Agricole et Industrielle des Tabacs de Cote D'Ivoire SA, IL (i) |
Cote D'Ivoire | In liquidation BP 418 - Bouake, Cote d'lvoire, Cote d'Ivoire |
74.6 |
| Compagnie Réunionnaise des Tabacs SAS |
France, St Pierre (La Reunion Island) |
Manufacture of cigarettes ZI n° 2 - BP 256 - 97457 Saint Pierre Cedex, La Reunion |
98.6 |
| Compañía de Distribución Integral de Publicaciones Logista SLU (iv) |
Spain | Distribution of published materials and other products C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
50.0 |
| Compañía de Distribución Integral Logista Holdings, S.A. (iii) |
Spain | Holding investments in subsidiary companies C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
50.0 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Compañía de Distribución | Poland | Distribution of tobacco products in Poland | 50.0 |
| Integral Logista Polska, sp. Z o.o. (SL) |
Avenida Jerozolimskie 133/131, 02-304 Varsaw, Poland | ||
| Compañía de Distribución | Spain | Distribution of tobacco products in Spain | 50.0 |
| Integral Logista S.A.U. | C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
||
| Congar International Corp | United States of | Manufacturing and distribution of mass market cigars | 63.1 |
| (Delaware) | America | Road 14, Km. 72.2, Ave. Antonio R. Barcelo, Cayey, DE, PR 00736, USA |
|
| Connecticut Shade Corporation | United States of | Holding investments in subsidiary companies | 63.1 |
| America | 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309 USA |
||
| Consolidated Cigar Holdings Inc | United States of | Holding investments in subsidiary companies | 63.1 |
| (vii) | America | 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309, USA |
|
| Cuban Cigar Brands BV (v) | Netherlands | Trademark owner | 63.1 |
| Antilles | N.V. Fides, 15 Pietermaai, Curaçao, Netherlands | ||
| Cyberpoint, S.L.U. | Spain | Antilles Distribution of POS software |
50.0 |
| C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
|||
| Direct Products Inc (Inactive) | United States of | Holding investments in subsidiary companies | 63.1 |
| America | 5900 North Andrews Avenue, Ste. 1100, Fort Lauderdale, FL, 33309, USA |
||
| Distribuidora de Ediciones SADE, SAU |
Spain | Distribution of published materials and other products in Spain |
50.0 |
| Calle B, esquina calle 4, s/n. Sector B, Polígono Industrial Zona Franca, 08040 Barcelona, Spain |
|||
| Distribuidora de las Rias SA | Spain | Distribution of published materials and other products | 50.0 |
| in Spain | |||
| Avda. Cerezos, Parcela D-28, Polígono Industrial PO.CO.MA.CO , 15190 Mesoiro, La Coruña, Spain |
|||
| Distribuidora del Este S.A.U. | Spain | Distribution of published materials and other products | 50.0 |
| in Spain | |||
| calle Frelix Rodriguez de la Fuente, 11, Parque Empresarial de Elche, 03203 Elche, Alicante, Spain |
|||
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Distribuidora del Noroeste SL | Spain | Distribution of published materials and other products in Spain C/ Gandarón, 34, interior, Vigo, Pontevedra, 36214, Spain |
50.0 |
| Dronas 2002, SLU | Spain | Industrial parcel and express delivery service Energía, 25-29; Polígono Industrial Nordeste, Sant Andreu de la Barca, Barcelona, 08740, Spain |
50.0 |
| Fabrica de Tabacos La Flor de Copan S de R.L. de CV |
Honduras | Holding investments in subsidiary companies Apartado Postal 209, Colonia Mejia-García, Santa Rosa de Copán, Honduras |
36.2 |
| Imperial Brands Holdings International B.V. |
The Netherlands | Provision of finance to other Group companies Slachtedijk 28a, 8501 ZA, Joure, Netherlands |
42.0 |
| Imperial Tobacco Brasil Comércio de Produtos de Tabaco Ltda. |
Brazil | Co-ordinating and monitoring of WEST license productions and distribution of tobacco products 5th andar (floor), Av. Brig. Faria Lima 3.729, itaim Bib, Sao Paolo, 04538-905, Brazil |
42.0 |
| Imperial Tobacco EFKA Management GmbH |
Germany | Manufacture of tobacco products in Germany Max-Born-Straße 4, Hamburg, 22761, Germany |
42.0 |
| Imperial Tobacco Germany Finance GmbH |
Germany | Holding investments in subsidiary companies Max-Born-Straße 4, Hamburg, 22761, Germany |
42.0 |
| Imperial Tobacco Hellas S.A. | Greece | Sales and marketing of tobacco products in Greece 300 Klisthenous Str, 15344 Gerakas, Attikis, Athens, Greece |
99.1 |
| Imperial Tobacco Holdings International B.V. |
The Netherlands | Provision of finance to other Group companies Slachtedijk 28a, 8501 ZA, Joure, Netherlands |
42.0 |
| Imperial Tobacco Kyrgyzstan LLC (i) |
Kyrgyzstan | Marketing and distribution of tobacco products in Kyrgyzstan 3 Floor, Prime Business Park, 100/2 Furmanov Str, Medeuskiy District, Almaty, 050000, Kazakhstan |
42.0 |
| Imperial Tobacco TKS a.d. (i) | Macedonia | Manufacture, marketing and distribution of tobacco products in Macedonia ul 11, Oktomvri 125, P O Box 37, 1000 Skopje, Macedonia |
99.1 |
| Imperial Tobacco TKS a.d. - Dege Kosove |
Kosovo | Manufacture, marketing and distribution of tobacco products in Kosovo Ahmet Krasniqi, Obj.Redoni C1 B Nr 23, Prishtina, Republic of Kosovo |
99.1 |
| Imperial Tobacco US Holdings BV |
The Netherlands | Holding investments in subsidiary companies Slachtedijk 28a, 8501 ZA, Joure, Netherlands |
63.1 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Imprimerie Industrielle Ivoirienne SA (i) |
Cote D'Ivoire | Printing company Zone Industrielle du Banco, Lots No 147-149-150, 01 BP 4124, Yopougon/Abdjan, Cote d'Ivoire |
72.8 |
| ITG Brands Holdco LLC | United States of America |
Holding investments in subsidiary companies 714, Green Valley Road, Greensboro, NC 27408, USA |
63.1 |
| ITG Brands, LLC | United States of America |
Marketing and distribution of tobacco products in the USA 714, Green Valley Road, Greensboro, NC 27408, USA |
63.1 |
| ITG Brands Holdpartner LP | United States of America |
Marketing and sale of tobacco products in United States of America 714 Green Valley Road, Greensboro, NC27408, United States of America |
36.2 |
| ITG Holdings USA Inc (ix) | United States of America |
Holding investments in subsidiary companies C/o The Corporation Trust Co, 1209 Orange Street, City of Wilmington, County of Newcastle, DE 19801, USA |
63.1 |
| La Mancha 2000, S.A., Sociedad Unipersonal |
Spain | Logistics services Av. de la Veguilla, 12-Nave A- Parcela S-120, Cabanillas del Campo, Guadalajara, 19171, Spain |
50.0 |
| Lao Tobacco Limited (i) | Laos | Manufacture and distribution of cigarettes in Laos KM 8, Thadeua Road, P O Box 181, Vientiane, Lao People's Democratic Republic |
53.0 |
| Logesta Deutschland Gmbh, Sociedad Unipersonal |
Germany | Long haul transportation in Germany Pilotystrasse, 4, 80538 München, Germany |
50.0 |
| Logesta France SARL | France | Long haul transportation in France Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Logesta Gestión de Transporte SAU |
Spain | Long haul transportation services in Spain C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
50.0 |
| Logesta Italia, S.R.L., Sociedad Unipersonal |
Italy | Long haul transportation in Italy Via Valadier, 37 - 00193 Roma, Italy |
50.0 |
| Logesta Lusa LDA | Portugal | Long haul transportation in Portugal Expanso da Area Industrial do Passil, Edificio Logista, Lote 1A, Palhava, Alcochete, Portugal |
50.0 |
| Logesta Polska Sp Zoo | Poland | Long haul transportation in Poland Aleje Jerozolimskie 133/32, 02/304 Varsovia, Poland |
50.0 |
| Logista France Holding SA | France | Holding investments in subsidiary companies Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Logista France SAS | France | Holding investments in subsidiary companies Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Logista Italia Spa | Italy | Long haul transportation in Italy Via Valadier, 37 - 00193 Roma, Italy |
50.0 |
| Logista Pharma SA | Spain | Distribution of pharmaceuticals Industria, 53-65, Poligono Industrial Nordeste, 08740, Sant Andreu de la Barca, Barcelona, Spain |
50.0 |
| Logista Pharma Canarias, SA | Spain | Pharmaceutical products logistics in Canary Islands C/ Entreríos Nave 3; Las Palmas de Gran Canaria, 35600, Spain |
50.0 |
| Logista Promotion et Transport SAS |
France | Marketing and distribution of tobacco products in France Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Logista, Transportes, Transitários e Pharma, Lda., Sociedad Unipersonal |
Portugal | Industrial parcel delivery and pharmaceutical logistics in Portugal Expanso da Area Industrial do Passil, Edificio Logista, Lote 1A, Palhava, Alcochete, Portugal |
50.0 |
| Logista-Dis SAU | Spain | Sale of tobacco products in Spain C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
50.0 |
| MABUCIG (Manufacture Burkinabe de Cigarette) |
Burkina Faso | Manufacture of cigarettes in Burkina Faso Zone Industrielle de Bobo-Dioulasso, Secteur No 19, Rue 19.14 No adressage 55, B.P. 94 - Bobo Dioulasso, Burkina Faso |
72.7 |
| Macotab SAS (Manufacture Corse des Tabacs) |
France, Bastia | Manufacture and sales of cigarettes Route Nationale 193, Furiani, 20600, France |
99.9 |
| Manufacture de Cigarettes du Tchad SA |
Tchad | Manufacture and distribution of cigarettes in Chad 0502 rue 1039, Arrondissement 1, N'DJamena, Chad |
95.0 |
| Max Rohr, Inc | United States of America |
Trademark owner 300 Delaware Avenue, Ste. 1267, Wilmington, DE,19801, USA |
63.1 |
| Midsid – Sociedade Portuguesa de Distribução, S.A., Sociedad Unipersonal |
Portugal | Wholesale of tobacco and other products Expanso da Area Industrial do Passil, Edificio Logista, Lote 1A, Palhava, Alcochete, Portugal |
50.0 |
| MTOA SA (i) | Senegal | Manufacture and sales of cigarettes in Senegal Km 2-5 Bld du Centenaire de la commune de Dakar, Dakar, Senegal |
97.3 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| NITAF Limited, IL (i) | Nigeria | In liquidation 28, Ground Floor, Ajasa Street, Off King George V Road, Onikan, Lagos, Nigeria |
50.0 |
| Promotora Vascongada de Distribuciones SA |
Spain | Distribution of published materials and other products in Biscay and Santander C/ Guipúzcoa, 5, Polígono Industrial Lezama Leguizamón, 48450 Echevarri, Vizcaya, Spain |
50.0 |
| Publicaciones y Libros SA | Spain | Publishing company C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
50.0 |
| REEMARK Gesellschaft für Markenkooperation mbH |
Germany | Dormant Max-Born-Straße 4, Hamburg, 22761, Germany |
42.0 |
| Reemtsma Cigarettenfabriken GmbH |
Germany | Manufacture and sale of tobacco products in Germany Max-Born-Straße 4, Hamburg, 22761, Germany |
42.0 |
| Reemtsma Kyrgyzstan OJSC (i) | Kyrgyzstan | Manufacture and sale of tobacco products in Kyrgyzstan 249 Ibraimov Street, Bishkek, Kyrghyz Republic, 720011, Kyrgyzstan |
41.9 |
| S3T Pte Ltd (i) | Singapore | Holding investments in subsidiary companies 80 Robinson Road, #02-00, 068898, Singapore |
51.0 |
| SACIMEM SA (i) | Madagascar | Manufacture of cigarettes in Madagascar 110 Antsirabe - Madagascar, Route d'Ambositra, BP 128, Madagascar |
65.4 |
| SITAB Industries SA (i) | Cote D'Ivoire | Manufacture of cigarettes in Cote D'Ivoire Rue de I'Industrie - Lot No 19, 01 - BP 607, Bouake, Cote d'Ivoire |
80.5 |
| SITAR Holding SAS | France (La Reunion Island) |
Holding investments in subsidiary companies Z.I n2, B.P. 256, 97457 Saint Pierre, IIe de la Reunion, France |
99.0 |
| Société Africaine d'Impression Industrielle SA (i) |
Senegal | Manufacture and distribution of cigarettes in Senegal route de Bel Air - Km 2200, Dakar, Senegal |
99.8 |
| Société Allumettiere Française SAS |
France | Manufacture and distribution of cigarettes Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Société des Cigarettes Gabonaises SA (i) |
Gabon | In liquidation 2381 bld Léon MBA, BP 2175, Libreville, Gabon |
87.8 |
| Société Industrielle et Agricole du Tabac Tropical SA (i) |
Congo | Manufacture and distribution of cigarettes in Congo Avenue de la Pointe Hollandaise, Mpila, BP 50, Brazzaville, Congo |
89.7 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Société Ivoirienne des Tabacs SA (i) (iii) |
Cote D'Ivoire | Manufacture and distribution of cigarettes in Ivory Coast Cocody-Nord, Quartier Gendarmerie, TF 5937, 01 B.P. 724 Abidjan |
74.1 |
| Société Marocaine des Tabacs SA |
Morocco | Manufacture and distribution of cigarettes in Morocco Boulevard La Corniche, Anfa Place, Immeublep Bureaux Batiments Ousst, Casablanca, 20180, |
99.9 |
| SOCTAM SA (i) | Madagascar | Morocco Manufacture and distribution of cigarettes in Mali 15 Rue Geoges V, Mahajanga, Madagascar |
50.5 |
| SOTCHADIS SAS | Chad | Non-trading 502 Rue 1039, BP 852, N'Djamena, Chad |
95.0 |
| Supergroup SAS | France | Wholesale of tobacco products Inmeuble Le Bristol, 27 Avenue des Murs du Parc, 94300 Vincennes, France |
50.0 |
| Tabacalera Brands Inc | United States of America |
Trademark owner 300 Delaware Avenue, Ste. 1267, Wilmington, DE 19801, USA |
63.1 |
| Tabacalera de Garcia Limited | Bermuda | Holding investments in subsidiary companies Claredon House, 2 Church Street, Hamilton, HM 11, Bermuda |
63.1 |
| Von Erl. Gmbh (i) | Austria | Sale of e-vapour products in the US and Europe Alte Landstrasse 27, 6060 Hall in Tirol, Austria |
60.0 |
| % | ||
|---|---|---|
| Name | Principal activity and registered address | owned |
| C H (Downton) Limited (ix) | Dormant | 25.0 |
| Hurlingham Business Park, Sulivan Road, London, SW6 | ||
| 3DU, England | ||
| F J (Downton) Limited | Dormant | 25.0 |
| Hurlingham Business Park, Sulivan Road, London, SW6 | ||
| 3DU, England | ||
| Hunters & Frankau Limited | Dormant | 25.0 |
| Hurlingham Business Park, Sulivan Road, London, SW6 | ||
| 3DU, England | ||
| Incentive Marketing Services (UK) Limited | Dormant | 25.0 |
| Hurlingham Business Park, Sulivan Road, London, SW6 | ||
| 3DU, England |
| Name Jacon Financial Services Limited (ix) Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Joseph Samuel & Son Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Knight Brothers Cigar Shippers Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Lancha House Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Melbourne Hart & Company Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Melbourne Hart Holdings Limited (ix) Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Morris & Morris Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Tabaco Torcido Traders Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England The English Import Company Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Tropic Tobacco Company Limited Dormant 25.0 Hurlingham Business Park, Sulivan Road, London, SW6 3DU, England Associates: Incorporated overseas Country of Name incorporation Principal activity and registered address owned Distribution of Cuban cigars in Germany 5th Avenue Products Trading Germany 27.5 GmbH (i) (iv) Schwarzenbergstr. 3-7 ; Waldshut-Tiengen, 79761, Germany Holding investments in subsidiary companies Azur Finances SA Cameroon 20.0 B.P 1105, Douala, Cameroon |
% | |||
|---|---|---|---|---|
| Principal activity and registered address | owned | |||
| % | ||||
25.0
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Cosmic Fog Vapours Company LLC |
United States of America |
Trademark owner, and sale of e-vapour products in USA and Europe C/O The Corporation Trust Co, 1209 Orange Street, City of Wilmington, County of Newcastle, DE19801 USA |
40.0 |
| Diadema Spa (i) | Italy | Distribution of Cuban cigars in Italy Via delle Terme Deciane, 10, Partita IVA 01213650995, Codice Fiscale 01374280509, 00153 Rome, Italy |
30.0 |
| Distribuidora de Publicaciones del Sur, S.A. |
Spain | Distribution of published materials and other products Carretera de la Esclusa, S/N - Pariela 2, Modulo 4, Sevilla, 41011, Spain |
25.0 |
| Distribución de Publicaciones Siglo XXI, Guadalajara |
Spain | Distribution of published materials and other products in Spain Francisco Medina y Mendoza, 2, 19171 Cabanillas del Campo, Guadalajara, Spain |
40.0 |
| Distribuidora Valenciana de Ediciones S.A. |
Spain | Distribution of published materials and other products in Valencia Pedrapiquers, 5; Polígono Industrial Vara de Quart, 46014 Valencia, Spain |
25.0 |
| DTPU Kaliman Caribe Dooel Scopje |
Macedonia | Distribution of Cuban cigars in Macedonia 5 Luj Pater Str., 1000 Scopje Center, Macedonia |
25.0 |
| Entreprises des Tabacs en Guinée (i) |
Guinée Conakry | Dormant B.P 3391, Conakry, Guinea |
34.0 |
| Havana House Cuban Products Specialist Limited (i) |
New Zealand | Distribution of Cuban cigars in New Zealand Level 16, 66 Wyndham Street, Auckland, New Zealand |
25.0 |
| Havana House Limited (i) | Canada | Distribution of Cuban cigars in Canada 9 Davies Avenue, Suite 112, Toronto ON, M4M 2A6, Canada |
25.0 |
| Importadora y Exportadora de Puros y Tabacos SA DE CV (IEPT) (i) |
Mexico | Marketing and distribution of Cuban cigars in Mexico Presidente Mazaryk numero 393 local 28, colonia Polanco, C.P. 11560 Delegación Miguel Hidalgo México D.F., Mexico |
25.0 |
| Intertabak AG (i) | Switzerland | Distribution of Cuban cigars in Switzerland and Liechtenstein Intertabak AG, Salinenstrasse 61, CH-4133 Pratteln, Entrepots: Salinenstrasse, 63, Switzerland |
25.0 |
| Kaliman Caribe doo Beograd | Serbia | Distribution of Cuban cigars in Serbia 5 Igmanska Str., Beograd, Serbia |
25.5 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Kaliman Caribe ood | Bulgaria | Distribution of Cuban cigars in Bulgaria 118 Bulgaria Blvd., Abacus Business Center, fl. 2, 1618 Sofia, Bulgaria |
25.5 |
| Kaliman Caribe Tirana Sh. p.k. | Albania | Distribution of Cuban cigars in Albania Sheraton Tirano Hotel and Tower, Italia Sq., fl. 1, Tirana, Albania |
25.5 |
| Kaliman Caribe yer LLC | Armenia | Distribution of Cuban cigars in Armenia V. Papazyan / 16a/ 17; Yerevan, 0012, Armenia |
25.5 |
| Lippoel Tobacco Corporation International NV |
Netherlands Antilles |
Distributor of Cuban leaf Pietermaai 123, P.O. BOX 897. Willemstad, Curacao, Netherlands Antilles |
27.5 |
| Logista Libros SL | Spain | Distribution of books Avda. Castilla La Mancha, 2 - Naves 3-4 del Polígono Industrial La Quinta, Cabanillas del Campo, Guadalajara, Spain |
25.0 |
| Manufacture Mauritanienne des Tabacs |
Mauritanie | Manufacture and import of tobacco products Nouakchott, Mauitanie |
34.6 |
| Maori Tabacs, S.A. (i) | Andorra | Distribution of Cuban cigars in Andorra Av. Pont De La Tosca, 13, Andorra |
25.0 |
| New Mentality Limited (i) | British Virgin Islands |
In liquidation Portcullis TrustNet Chambers, Road Town, Tortola, 3444, British Virgin Islands |
25.0 |
| Pacific Holding (Thailand) Company Limited (i) (vi) |
Thailand | Holding investments in subsidiary companies 39/7 Soi Ruamrudee 2, Ploenchit Road, Lumpini, Pathumwan, Bangkok 10330 Thailand |
25.0 |
| Phoenicia Beirut SAL (i) | Lebanon | Retail in Lebanon New Starco Center, Sixth Floor, Beirut Central District, Lebanon |
25.0 |
| Phoenicia TAA Cyprus Ltd (i) | Cyprus | Distribution of Cuban cigars in the Middle East and Africa 249, 28 Oct Street, Lophitis Business Center, Limassol, 3035, Cyprus |
25.0 |
| Pit Stop Limited (i) | British Virgin Islands |
In liquidation Portcullis TrustNet Chambers, Road Town, Tortola, 3444, British Virgin Islands |
25.0 |
| Promotion et Distribution a Madagascar (i) |
Madagascar | Distribution of cigarettes in Madagascar Tour ZITAL Ankorondrano, Antananarivo, Madagascar |
33.4 |
| Société Internationale des Tabacs Malgaches (i) |
Madagascar | Leaf processing BP 270, 401 Mahajanga, Madagascar |
47.9 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Société Nationale des Tabacs et | Mali | Manufacture and distribution of cigarettes in Mali | 28.0 |
| Allumettes du Mali SA (i) | Route Sotuba - Z.I., BP 59, Bamako, Mali | ||
| Terzia SPA | Italy | Wholesale to tobacconists in Italy | 34.0 |
| Via Valadier, 37 - 00193 Roma, Italy | |||
| The Pacific Cigar (Thailand) Co | Thailand | Distribution of Cuban cigars in Thailand | 25.0 |
| Limited (i) (vii) | 25 Alma Link Building, 2nd Floor, Soi Chidlom, Ploenchit | ||
| Road, Kwaeng Lumpinee, Khet Patumwan, Bangkok | |||
| Metropolis, Bangkok, Thailand | |||
| The Pacific Cigar Co. (Singapore) | Singapore | Distribution of Cuban cigars in Singapore | 25.0 |
| Pte Limited (i) | 150 Cecil Street, #15-01, 069543, Singapore | ||
| The Pacific Cigar Company | Australia | Distribution of Cuban cigars in Australia | 25.0 |
| (Australia) Pty Limited (i) | 17/23, Bowden Street Australia, Alexandria, NSW 2015, | ||
| Australia | |||
| The Pacific Cigar Company | Macau | Distribution of Cuban cigars in Macau | 25.0 |
| (Macau) Limited (i) | Avenida Praia Grande No. 369-371, Edif. Keng Ou 8 | ||
| Andar, A, Macau | |||
| The Pacific Cigar Company | Malaysia | Dormant | 25.0 |
| (Malaysia) SDN BHD (i) | 83A, Jalan SS15/5A, 47500 Subang Jaya, Selangor Darul, | ||
| Ehsan, 47500, Malaysia | |||
| The Pacific Cigar Company (New | New Zealand | Distribution of Cuban cigars in New Zealand | 25.0 |
| Zealand) Limited (i) | Level 16, 66 Wyndham Street, Auckland, New Zealand | ||
| The Pacific Cigar Company | China | Distribution of Cuban cigars in Asia | 25.0 |
| Limited (i) | 21/F., Guangdong Investment Tower, 148 Connaught | ||
| Road Central, Hong Kong | |||
| The Pacific Cigar International | British Virgin | Distribution of Cuban cigars in Asia | 25.0 |
| Co Limited (i) | Islands | Akara Bldg., 24 De Castro Street, Wickhams Cay I, Road | |
| Town, Tortola, British Virgin Islands |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Altabana SL (i) | Spain | Holding investments in subsidiary companies involved in the marketing and sale of Cuban cigars Paseo de la Castellana, 143 - 10ºA, Madrid, 28046, Spain |
50.0 |
| Comercial Iberoamericana SA (i) | Spain | Wholesale and distribution of tobacco products Paseo de la Castellana, 143 - 10ºA, Madrid, 28046, Spain |
50.0 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| Compañía de Distribución Integral Logista S.A.U. y GTECH Global Lottery, S.L.U., U.T.E. |
Spain | Services and distribution C/ Trigo, 39 - Polígono Industrial Polvoranca, Leganés, Madrid, 28914, Spain |
25.0 |
| Corporación Habanos SA (i) | Cuba | Export of cigars manufactured in Cuba Centro de Negocios Miramar, Edificio Habana, 3ra. Planta, Avenida 3ra. e/ 78 y 80, C.P.: 11300, Cuba |
50.0 |
| Coprova SAS (i) | France | Distribution of Cuban cigars in France 171 Avenue Jean Jaures - Paris CEDEX 19, 75927, France |
50.0 |
| Cuba Cigar, S.L. (i) | Spain | Distribution of Cuban cigars in the Canary Islands Avenida Andrés Perdomo S/N, Edificio de Zona Franca, Planta Baja, Puerto de la Luz (Las Palmas de Gran Canaria), 35008, Spain |
50.0 |
| Cubacigar (Benelux) N.V. (i) | Belgium | Distribution of cigars in Belgium Reutenbeek, 5 - 3090 Overijse, Belgium |
50.0 |
| Dalso, S.R.L. (i) | Dominican Republic |
Distribution of Cuban cigars in Republic Dominican Avenida Gustavo Mejía Ricart esquina Avenida Abraham Lincoln, Torre Piantini, sexto piso, Ensanche Piantini, Santo Domingo, Distrito Nacional, Dominican Republic |
50.0 |
| Empor - Importação e exportação, SA (i) |
Portugal | Distribution of tobacco products in Portugal Rua João Santos, Lote 2, Lisboa, 1300-325, Portugal |
50.0 |
| Global Horizon Ventures Limited |
Hong Kong | Sales and marketing of cigarettes in Asia Room 3907-08, 39th Floor, Hopewell Centre, 183 Queens Road East, Wanchai, Hong Kong |
50.0 |
| Habanos Nordic AB (i) | Sweden | Distribution of Cuban cigars in Scandinavia August Barks gata 30B SE-42132 Västra Frölunda - Sweden |
50.0 |
| Infifon APS (i) | Denmark | Holding investments in subsidiary companies 21, INFIFON ApS, Harbour House, Sundkrogsgade, 2100 Copenhagen, Denmark |
50.0 |
| Infifon Hong Kong Limited (i) | China | Distribution of Cuban cigars in China 21/F, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong |
50.0 |
| Infifon I, BV (i) | The Netherlands | Holding investments in subsidiary companies Parklaan 34, Rotterdam, 3016 BC, Netherlands |
50.0 |
| Infifon II NV (i) | Netherlands Antilles |
Distribution of Cuban cigars in Russia Van Engelenweg 23, Curaçao, Netherlands Antilles |
50.0 |
| Country of | % | ||
|---|---|---|---|
| Name | incorporation | Principal activity and registered address | owned |
| International Cubana de Tabaco | Cuba | Manufacture of cigarillos in Cuba | 50.0 |
| SA (i) | Ave. Independencia #34501 entre Ave. 345 y 1ºde | ||
| Mayo, Municipio Boyeros, Ciudad de La Habana, Cuba | |||
| Intertab SA (i) | Switzerland | Holding investments in subsidiary companies | 50.0 |
| Société Fiduciaire Suisse-Coopers & Lybrand S.A., Route | |||
| de la Glâne 107, Villars-sur-Glâne, 1752, Switzerland | |||
| Promotora de Cigarros SL (i) | Spain | Sales and marketing of cigars manufactured in Cuba | 50.0 |
| Parque Empresarial Cristalia, Vía de los Poblados, 3, | |||
| Edificio 7/8, Madrid, 28033, Spain | |||
| Puro Tabaco SA (i) | Argentina | Distribution of Cuban cigars in Argentina and Chile | 50.0 |
| Lavalle 445, Piso 1, Buenos Aires, Argentina | |||
| Top Cigars Corporation LLC (i) | Russia | Distributor of Habanos in Russia | 50.0 |
| Dimitrovskoe shosse 167, 127204 Moscow, Russian | |||
| Federation | |||
| Xinet SA (i) | Uruguay | Dormant | 50.0 |
| Ciudadela 1373, Montevideo, Uruguay |
The Group also owns the following partnerships:
| Principal activity, registered address and principal place of | ||
|---|---|---|
| Name | Country | business |
| Imperial Tobacco Kazakhstan LLP (i) |
Kazakhstan | Marketing and distribution of tobacco products in Kazakhstan Registered address and principal place of business: 3rd Floor, Prime Business Park, 100/2 Furmanov Str, Medeuskiy District, Almaty, 050000, Kazakhstan |
| Imperial Tobacco (Efka) GmbH & Co. KG |
Germany | Manufacture of tubs in Germany Registered address: Postfach 1257, Industriestrasse 6, Trossingen, 78636, Germany Principal place of business: Industriestrasse 6, Postfach 1257, D 78636 Trossingen, Germany |
The subsidiaries listed were held throughout the year and the consolidated Group financial statements include all the subsidiary undertakings identified. All dormant UK entities have taken the exemption available to not have an audit of their financial statements.
Unless otherwise stated the entities are unlisted, have 1 type of ordinary share capital and a reporting period ending on 30 September each year.
The percentage of issued share capital held by the immediate parent and the effective voting rights of the Group are the same except for Imperial Tobacco Italia Srl where the entire share capital, and therefore 100 per cent of the voting rights, are held by a number of Group companies, and Compañía de Distribución Integral Logista SAU, Logista France SAS, and Logista Italia SpA are 100 per cent owned subsidiaries of Compañía de Distribución Integral Logista Holdings SA, which is itself 50.01 per cent owned by Altadis SAU.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.